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Summary of thesis 
Laparoscopic adrenalectomy (LA) has become the procedure of choice for most adrenal 
pathologies. A number of uncertainties remain which include:  
1.  The impact of variable adrenal vasculature on LA. 
2.  The blood supply to the adrenal remnant after subtotal adrenalectomy.  
3.   Haemodynamic changes during LA for phaeochromocytoma resection. 
4.   The role of LA for large adrenal tumours (≥6cm). 
5.   The outcomes of patients undergoing open adrenalectomy (OA) in a series where LA 
is performed routinely. 
6.  The role of LA for isolated adrenal metastasis. 
The aim of the thesis was to examine these uncertainties using our adrenalectomy series (Jan 
1999 – Jan 2009) and anatomical dissection. 
We found: 
1.  The main adrenal vein was remarkably constant and multiple small arteries and veins 
surround the adrenal gland. 
2.  During laparoscopic subtotal adrenalectomy, a non functioning adrenal remnant would 
be unlikely due to an inadequate arterial supply or due to division of the main adrenal 
vein. 
3.    LA for phaeochromocytoma was associated with increased episodes of severe 
intraoperative hypertension (systolic blood pressure 200-220mmHg) when compared 
to the laparoscopic resection of other adrenal tumours. There were no other significant 
differences in terms of hypotensive episodes, cardiac arrhythmias or intravenous fluid 
requirements.   11
4.  In the absence of local invasion, LA for tumours ≥6cm has shown that oncological 
outcome and post-operative morbidity were comparable to LA for tumours <6cm. 
5.  In a series where LA was routine, OA was performed infrequently. In the absence of 
the requirement for an additional open procedure, OA was a demanding procedure 
associated with resection of adjacent structures and high local recurrence rates. 
6.  The recovery and oncological outcomes for isolated adrenal metastasis from a renal 
origin compared very favourably to other series where a more selective policy for 
laparoscopy was adopted.   
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1 Introduction 
1.1 Adrenal gland anatomy 
1.1.1 Macroscopic anatomy 
General 
The adrenal glands lie directly above the upper poles of the kidneys. They are surrounded by 
perinephric fat and enclosed within their own compartment of the renal fascia. The glands are 
recognizable by their golden yellow appearance.   
Right adrenal gland 
The right gland is pyramidal in shape. The anatomical relationships are illustrated in Figure 1.1. 
The anterior surface is overlapped by the inferior vena cava (medially) and the bare area of the 
liver. It lies on the diaphragm, with its base directly above the upper pole of the right kidney. 
Left adrenal gland 
The left adrenal gland is said to look like a workman’s cap. The blood supply and some of the 
anatomical relationships are illustrated in Figure 1.1. The anterior surface is overlapped by the 
peritoneal wall of the lesser sac and the distal pancreas and splenic artery (inferiorly). It lies on 
the left crus of the diaphragm, draped over the medial border of the left kidney. 
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Figure 1.1 Diagram showing the blood supply and position of the adrenal glands in relation to 
the aorta, inferior vena cava and kidneys 
 
                   
Adrenal gland blood supply 
The adrenal gland is supplied by multiple small arterial branches which ramify over the adrenal 
capsule. The arterial branches originate from three sources: the inferior phrenic artery, the 
aorta and the renal arteries (Gray & Williams, 1989)  
The drainage of the adrenal gland is usually by a single vein: the right adrenal vein into the 
inferior vena cava and the left adrenal vein into the left renal vein. The main right adrenal vein 
may only be a few millimetres (Gray & Williams, 1989)  (Sinnatamby & Last, 1999). 
  
Any variability of adrenal gland vasculature is not clear from standard anatomy texts 
(Sinnatamby & Last, 1999) (Gray & Williams, 1989).  Nor is it clear, in the presence of adrenal 
pathology, if venous variability or the number of arterial branches would increase. This could 
have implications in terms of bleeding complications during adrenalectomy or to the blood 
supply of the adrenal remnant when performing a subtotal adrenalectomy. We felt the   14
magnified view of laparoscopy (2.5-3 times normal) may allow a more accurate view of the 
vasculature compared to the traditional open techniques for adrenal pathologies.   
1.1.2 Microscopic anatomy 
The adrenal gland is separated into the adrenal cortex (yellow colour) and medulla (grey 
colour). The gland is surrounded by a capsule composed of collagen. 
The adrenal cortex is divided into three zones: the outer glomerulosa, the intermediate 
fasciculata and the inner reticularis. These three zones produce mineralocorticoids, 
glucocorticoids and sex steroids respectively. 
The adrenal medulla consists of groups of chromaffin cells (phaeochromocytes) separated by 
venous sinusoids. Chromaffin cells synthesize, store and release catecholamines (epinephrine, 
norepinephrine) into the venous sinusoids. 
Paraganglia are extra-adrenal aggregations of chromaffin tissue which tend to be distributed 
near or in the autonomic nervous system.  
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1.2 Adrenal physiology 
1.2.1 Adrenal cortex 
The hormones of the adrenal cortex are derivatives of cholesterol. The three hormone classes 
secreted in physiological significant amounts are: 
Glucocorticoids (produced from the zona glomerulosa): cortisol is the major glucocorticoid in 
humans 
Mineralocorticoids  (produced from the zona fasciculata): aldosterone is the major 
mineralcorticoid 
Androgens  (produced from the zona reticularis): dehydroepiandrosterone and 
androstenedione 
Of these three hormone classes, the only one essential for life is glucocorticoids. 
 
Glucocorticoids 
The negative feedback control of cortisol secretion is illustrated by the hypothalamic-pituitary-
adrenal (HPA) axis (Figure 1.2). Plasma cortisol level is controlled by the sum of neural factors 
acting on the hypothalamus and the effect of negative feedback of cortisol action on the 
anterior pituitary gland and hypothalamus. The effects of glucocorticoids are summarised in 
Table 1.1.  
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Figure 1.2 Control of the hypothalamic-pituitary-adrenal axis 
  
 
 
 
 
 
 
 
 
Table 1.1 Action of glucocorticoids 
Action 
 
Increase plasma glucocorticoids  Decrease plasma glucocorticoids 
 
 
Metabolism 
 
Protein catabolism 
Hepatic glycogenesis 
 
Protein synthesis 
Hepatic glycogenolysis 
Hypothalamus 
Anterior 
Pituitary 
CORTISOL 
Adrenal cortex 
Negative 
feedback 
Corticotrophin releasing hormone 
ACTH 
Tissue actions 
Circadian 
rhythm (+/-)  Stress (+)   17
Hepatic gluconeogenesis 
Lipolysis 
 
 
Vascular  Vascular tone  Impair vascular tone 
 
Immunological 
 
Immunosuppression 
 
 
Inflammatory  Inhibit the inflammatory response to 
injury 
 
 
Nervous system 
 
Behaviour and mood effects 
 
 
Bone 
 
Bone dissolution 
 
Bowel absorption of calcium 
  
 
Cushing’s syndrome is the term given to prolonged exposure to excessive glucocorticoids. 
Typical clinical findings would include: moon face, truncal obesity, hirsutism, hypertension and 
easy bruising. This can be endogenous or exogenous. Exogenous causes are the most 
common. This is often due to the iatrogenic administration of glucocorticoids for chronic 
medical pathologies.  
For endogenous Cushing’s syndrome the causes can be divided into ACTH-dependant and 
ACTH-independent. Table 1.2 illustrates the common causes of excessive glucocorticoid 
production. The most common cause of endogenous Cushing’s syndrome is Cushing’s 
disease. Occasionally, bilateral adrenalectomy is indicated for select patients with persistent 
Cushing’s disease. This includes failure following pituitary resection. Adrenalectomy is usually 
indicated for ACTH-independent Cushing’s syndrome.      
Table 1.2 Endogenous causes of Cushing’s syndrome 
ACTH-dependant 
Cushing’s disease (pituitary adenoma) 
Ectopic ACTH syndrome (eg lung cancer) 
 
ACTH-independent 
Adrenal adenoma 
Adrenocortical carcinoma (rare) 
Primary pigmented nodular adrenal dysplasia (rare) 
ACTH-variable 
Macronodular hyperplasia (rare) 
Mineralocorticoids   18
Aldosterone secretion is regulated by a number of factors: renin-angiotensin system in a 
feedback mechanism, ACTH from the pituitary gland and direct stimulatory effect on the 
adrenal cortex by a rise in plasma potassium or decrease in plasma sodium. 
Aldosterone increases the reabsorption of sodium from the kidneys and excretion of potassium 
and hydrogen. Excessive secretion of aldosterone leads to hypokalaemia and an increase in 
the extracellular volume with resultant hypertension.    
Excessive aldosterone production can be primary or secondary. Secondary aldosteronism is 
caused by elevated renin and angiotensin II levels. This results from a low effective arterial 
blood volume. Examples include: congestive cardiac failure, liver cirrhosis and nephrosis. The 
causes of primary aldosteronism are listed in Table 1.3. The most common cause is an 
aldosterone-producing adrenocortical adenoma (Conn’s syndrome). It is important to 
differentiate between idiopathic hyperaldosteronism and Conn’s adenoma. Unilateral 
adrenalectomy is curative for Conn’s adenoma but not for the other.  
Table 1.3 Aetiology of primary aldosteronism 
Aetiology 
 
Percent 
 
Aldosterone producing adrenocortical adenoma (Conn’s 
syndrome) 
 
 
65% 
 
Idiopathic hyperaldosteronism with bilateral adrenal 
hyperplasia 
 
 
25% 
 
Primary adrenal hyperplasia 
 
 
5% 
 
Renin-responsive aldosterone-producing adenoma 
 
 
5% 
 
Adrenocortical carcinoma 
 
 
rare 
 
 
 
Androgens   19
Secretion of androgens is under the control of ACTH from the pituitary gland. The main effects 
of androgen secretion are: masculinizing effects, promotion of protein anabolism and growth. 
Adrenal androgens cause very little masculinizing effects when secreted in normal amounts. 
However, when secreted in excessive amounts can cause severe masculinization. In males 
this can lead to precocious pseudopuberty and in females adrenogenital syndrome. 
Adrenocortical insufficiency 
Adrenocortical insufficiency is due to inadequate secretion of glucocorticoid and 
mineralcorticoid hormones. Adrenal insufficiency can be primary or secondary. Primary adrenal 
insufficiency occurs when there is direct destruction of the adrenal glands. This is usually due 
to Addison’s disease (autoimmune related adrenal atrophy). Secondary adrenal insufficiency 
results from an impairment of ACTH secretion due to pituitary or hypothalamic disorders. 
Addisonian crisis may occur in this group of patients following acute withdrawal of steroids, 
severe sepsis or trauma. Mainstay of treatment would be fluid resuscitation and hydrocortisone 
administration.   
 
1.2.2 Adrenal medulla 
The adrenal medulla secretes catecholamines from the chromaffin cells. The catecholamines 
are: norepinephrine, epinephrine and dopamine. In humans, most catecholamine output is 
epinephrine. 
Catecholamines 
Catecholamine secretion from the adrenal medulla is under neural control. Increased adrenal 
catecholamine secretion is part of the diffuse sympathetic discharge in emergency situations. 
This is termed the emergency function of the sympathoadrenal system. It is a way for preparing 
individuals for fight or flight.  The effects of catecholamines are shown in Table 1.4. 
Table 1.4 Actions of catecholamines   20
  Catecholamine Effect 
 
 
Metabolism 
 
NE, E 
 
Increase glycogenolysis 
Mobilisation of fat 
Rise in metabolic rate 
 
Cardiovascular 
β1 receptors 
β2 receptors 
α1 receptors 
 
NE, E, dopamine 
E 
NE 
 
Increase force and rate of contraction 
Dilates blood vessels in skeletal muscle 
Produces vasoconstriction in all organs  
 
NE= norepinephrine, E= epinephrine 
Abnormal elevated levels of catecholamine can result from tumours that arise from adrenal 
chromaffin cells. These are called phaeochromocytomas. Classic symptoms and signs include: 
episodic headaches, palpitations and sweating associated with sustained or paroxysmal 
hypertension (Werbel & Ober, 1995).  Adrenalectomy is the treatment of choice for sporadic or 
hereditary unilateral phaeochromocytoma. For patients with inherited syndromes with bilateral 
phaeochromocytomas bilateral or cortex-sparing adrenalectomy must be considered (Petri, van 
Eijck, de Herder, Wagner, & de Krijger, 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
1.3 Clinical presentation   21
Clinical presentation can often be non-specific or the patient can present after incidental 
adrenal gland imaging.  
1.3.1 Conn’s syndrome 
The symptoms and signs are non-specific and include hypertension and hypokalaemia. 
1.3.2 Cushing’s syndrome 
Symptoms and signs include: truncal obesity, decreased libido, thin skin, hypertension, 
hirsutism, depression, easy bruising, glucose intolerance and general weakness. 
1.3.3 Phaeochromocytoma 
Phaeochromocytoma is suspected in patients with: episodic episodes of headaches, sweating 
and palpitations with poorly controlled persistent or intermittent hypertension. 
1.3.4 Incidentaloma  
Adrenal incidentaloma is an adrenal tumour (≥1cm) discovered on an imaging study for other 
unrelated pathologies. Over the last one and a half decades incidental adrenal gland imaging is 
increasingly performed as computed tomography for other abdominal pathologies has become 
common. This has led to an increase in patients with an incidental adrenal tumour referred for 
surgical and endocrine assessment (Saunders et al., 2004). Presently between 4-6% of the 
imaged population have incidentalomas (Bovio et al., 2006)(Kloos, Gross, Francis, Korobkin, & 
Shapiro, 1995). Almost all these lesions will be benign in a patient without a known history of 
cancer (Song, Chaudhry, & Mayo-Smith, 2007)(Young, 2000). 
 
 
 
 
 
1.4 Assessment of adrenal tumours   22
Adrenal tumours are characterised by radiological and hormonal assessment.  
1.4.1 Radiological assessment  
The main modalities of choice in the evaluation of an adrenal tumour are computed 
tomography (CT) or magnetic resonance imaging (MRI). Most investigators use CT as the 
initial modality of choice as it is more readily available and cheaper.  Occasionally when CT or 
MRI studies are inconclusive patients are referred for combined positron emission tomography 
and computed tomography (PET-CT). 
Adrenal tumours can be characterized using imaging alone. Characterisation of the adrenal 
tumour depends on a number of factors which include: morphology, perfusion differences and 
intracellular lipid concentration (Boland, Blake, Hahn, & Mayo-Smith, 2008). 
Morphology appearances which may suggest malignancy include: increased size, large 
necrotic areas, increased heterogeneity, irregular borders and local invasion. Available data 
suggests, at a size threshold of ≥4cm the likelihood of malignancy doubles and is more than 
ninefold higher for tumours ≥8cm (Sturgeon, Shen, Clark, Duh, & Kebebew, 2006). 
Lipid sensitive imaging by CT or MRI exploit the fact that most adenomas contain abundant 
intracellular fat where as almost all malignant lesions do not (Korobkin et al., 1996). It has been 
reported an unenhanced CT densitometry technique can effectively differentiate many adrenal 
adenomas from malignant adenomas. Figure 1.3 shows a typical adrenal adenoma from an 
unenhanced CT. If the CT attenuation threshold is set at 10 hounsfield units the sensitivity and 
specificity for characterising adenomas versus non-adenomas has been reported 71% and 
98% respectively (Boland et al., 1998). This method has limitations which include: up to 30 % 
of adenomas are lipid poor and most CT scans for other pathologies are contrast enhanced 
(Boland et al., 2008). Therefore, using attenuation values in these cases would be considered 
indeterminate or difficult to interpret.    23
More recently studies have reported improved results using CT perfusion washout scans or 
chemical shift MR imaging. For CT, an initial non-contrast or contrast enhanced scan is 
performed followed by a contrast enhanced examination after a variable delay (often 15 
minutes). Benign lesions typically demonstrate more than 50% washout. A threshold 
enhancement washout value is then calculated. Chemical shift MR imaging utilises the different 
resonant frequencies of fat and water protons. Benign lesions typically show signal intensity 
decrease when compared with in-phase images. Figure 1.4 illustrates axial MRI images of an 
11cm adrenal mass. The size and unchanged signal intensity makes this highly suspicious of 
malignancy. Histology confirmed the suspicion. From the available data, CT perfusion washout 
scan appears to offer the highest sensitivity and specificity for adrenal adenoma 
characterization (Park, Kim, Kim, & Lee, 2007). 
PET-CT allows adrenal lesion morphology and metabolic activity to be coregistered on the 
same image. This would allow a more accurate anatomic localization of any PET abnormalities. 
In current practice patients would only be referred for PET-CT rarely if CT or MR results are 
inconclusive (Boland et al., 2008). 
123  I-MIBG is concentrated in catecholamine storage vesicles. A meta-iodobenzylguanidine 
(MIBG) scan can help identify phaeochromocytoma, extra-adrenal phaeochromocytoma and 
metastatic deposits from the phaeochromocytoma. 
 
Despite the above techniques, the only reliable imaging findings to differentiate between 
malignant and benign adrenal tumours remain the presence of regional invasion or metastatic 
disease. Figure 1.5 shows an MR scan of a locally invasive adrenal mass. 
 
 
   24
Figure 1.3 Unenhanced CT of a left adrenal adenoma (arrow) 
 
Figure 1.4 Axial MR images of a large right adrenocortical carcinoma. (a) T1-weighted in-
phase image shows signal intensity (long arrow) similar to spleen (short arrow). (b) T1 
weighted opposed phase image shows unchanged signal density 
a, 
 
b, 
   25
Figure 1.5 MR image of a locally invasive adrenocortical carcinoma (long  arrow). (a) Coronal 
slice showing invasion into kidney (short arrow). (b) Tumour thrombus into inferior vena cava 
(arrow).  
a, 
 
b, 
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1.4.2 Hormonal assessment 
All adrenal tumours require hormone evaluation. The hormone studies are performed to check 
for: phaeochromocytoma, Cushing’s syndrome and Conn’s syndrome. 
A phaeochromocytoma screen included a 24 hour urine collection for catecholamines 
(norepinephrine, epinephrine and dopamine) and metabolites (metanephrine, normetanephrine, 
vanillylmandelic acid). Cushing’s syndrome/disease assessment included 24 hour urinary 
cortisol, serum cortisol and plasma ACTH, low dose dexamethasone suppression test and 
plasma androgen measurements. A Conn’s syndrome screen included urea and electrolytes, 
plasma renin and aldosterone levels. Adrenal vein sampling can be used for patients with 
suspected Conn’s syndrome when imaging does not demonstrate an obvious adenoma. 
 
1.4.3 Adrenal biopsy 
Ultrasound or computed tomography guided fine needle aspiration (FNA) is unhelpful to 
distinguish between benign and malignant adrenal tumours due to the high false negative rate 
(Sasano, Shizawa, & Nagura, 1995).  The only potential use of FNA is to help diagnose 
metastasis when adrenal resection is not planned and detection would alter patient 
management (Lee et al., 1998). 
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1.5 Indications for adrenalectomy 
Adrenalectomy is indicated for all hormonally active adrenal lesions, suspicion of adrenal 
malignancy on imaging (size ≥4cm, local invasion, tumour heterogeneity, high attenuation and 
irregular tumour margins) and isolated adrenal metastases. 
Management of a non functioning adrenal lesion remains debatable. All authors advocate 
resection of large ≥6cm non functional adrenal tumours due to the increased risk of 
malignancy. No prospective controlled studies exist for the role of adrenalectomy for adrenal 
masses of 3-6 cm. Different authors have advocated size tumour thresholds of 3,4,5 and 6cm 
for resection of non functioning  adrenal tumours (Duh, 2002)(G. B. Thompson & Young, 
2003)(Eldeiry & Garber, 2008). Sturgeon et al characterized the relationship between tumour 
size and malignancy risk compared the National Cancer Institute’s Surveillance, Epidemiology, 
and End Results (SEER) database for adrenocortical carcinoma with their own experience with 
benign adrenal cortical adenomas from a similar time period. From the SEER database 457 
adrenal cortical carcinomas were identified (376 had size data) and 47 patients from their own 
series with benign adrenal cortical adenomas. The authors found a tumour threshold of 4cm 
has a sensitivity and specificity of 96% and 52% for malignancy versus 90% and 80% for a 
tumour threshold of 6cm. The authors advocated that all tumours ≥4cm should be surgical 
resected (Sturgeon et al., 2006).  
In the current series indications for adrenalectomy included: all hormonally active adrenal 
lesions, all tumours ≥ 4cm, suspicion of adrenal malignancy on imaging (local invasion, tumour 
heterogeneity, high attenuation and irregular tumour margins) and isolated adrenal metastases. 
Resection of non functioning adrenal tumours <4cm was indicated for patients with evidence of 
tumour growth on serial radiological imaging. The only contraindications to laparoscopy were 
locally invasive adrenal carcinoma (laparoscopic en-bloc nephrectomy was performed after   28
2007 if there was isolated local invasion to the kidney) or the requirement of an additional open 
surgical procedure. 
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1.6 Perioperative management 
1.6.1 Bilateral adrenalectomy 
Bilateral adrenalectomy can be indicated following relapse after pituitary surgery, bilateral 
adrenal hyperplasia or hereditary phaeochromocytoma. Perioperative intravenous 
hydrocortisone is required to prevent acute adrenal insufficiency. When oral intake has been 
established lifelong oral steroids are required. Increased doses are required at times of stress 
(eg trauma, infection).  
1.6.2 Autonomous cortisol secretion 
For patients with autonomous cortisol secretion after hormonal testing a perioperative ‘stress 
dose’ of hydrocortisone is recommended. A post operative in-patient short SYNACTHEN test 
would follow. If the test indicates adrenal insufficiency (low level of stimulated cortisol) steroid 
replacement should continue as this indicates HPA axis suppression. Patients are then 
reviewed as an out-patient to test for HPA axis recovery. If the test indicates adequate cortisol 
response (functioning HPA axis) steroid replacement therapy can stop.  
1.6.3 Phaeochromocytoma 
The perioperative medical management of patients with phaeochromocytomas is essential to 
reduce the effects of circulating catecholamines (Plouin, Duclos, Soppelsa, Boublil, & 
Chatellier, 2001)(Kinney et al., 2000). These can include severe hypertension (systolic blood 
pressure >200mmHg), tachycardia, arrhythmias and death. Immediate surgery is rarely 
essential. 
Medical management aims to control blood pressure, heart rate and arrhythmias. Traditional 
preoperative regimens have included phenoxybenzamine (a long-acting non-selective alpha 
blocker) and propanolol (beta blocker) (Ross, Prichard, Kaufman, Robertson, & Harries, 1967). 
Other agents have been used effectively including selective alpha blockers and calcium   30
channel antagonists (Prys-Roberts & Farndon, 2002)(Lebuffe et al., 2005). No trial exists 
comparing the traditional regimen with other medical managements. 
Despite preoperative medical management, intraoperative tumour manipulation or introduction 
of pneumoperitoneum (laparoscopic adrenalectomy) may cause severe haemodynamic 
responses requiring further treatment with short acting alpha blockers (eg phentolamine) or 
short acting beta blockers (eg labetalol) (Joris et al., 1999)(Tauzin-Fin, Sesay, Gosse, & 
Ballanger, 2004). 
 
In the current series, we used a preoperative phenoxybenzamine regimen (fully described in 
Chapter 5) and felt complete alpha blockade was achieved in all cases. Preoperative beta 
blockade was not routinely administered. As a result, we felt using this regimen and a specialist 
endocrine, anaesthetic and surgical team the perioperative haemodynamic stability of 
laparoscopic adrenalectomy (LA) for phaeochromocytoma has improved to such a degree that 
they may now be comparable to LA for other non-catecholamine secreting adrenal tumours. 
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1.7 Adrenal gland pathology  
Adrenal tumours can be divided into those arising from the adrenal cortex, those arising from 
the adrenal medulla, those arising from other components of the adrenal gland or those that 
metastasize to the adrenal gland. 
1.7.1 Adrenocortical tumours 
Tumours arising from the adrenal cortex include adenomas and carcinomas. Adrenal cortical 
adenomas can be hormonally active or hormonally inactive. Hormonally active adenomas are 
classified according to the hormone secreted. Aldosterone producing adenoma is termed 
Conn’s syndrome or primary aldosteronism. Cortisol producing adenoma and is termed 
Cushing’s syndrome (ACTH-independent). Macronodular adrenal hyperplasia can also cause 
an ACTH-independent Cushing’s syndrome. These patients may require bilateral 
adrenalectomy.   Cushing’s disease is glucocorticoid excess caused by a pituitary adenoma 
(ACTH-dependent). In some circumstances bilateral adrenalectomy is required due to 
persistent hypercortisolism after failed neurosurgical intervention.  
Hormonally inactive adenomas are termed non-functioning adrenal cortical adenomas or 
adrenal incidentalomas. These are usually detected when radiological imaging was performed 
for other pathology.  
On histopathological examination it is not generally possible to differentiate between the 
functional types of adenoma. This is dependant on prior hormone assessment. 
1.7.2 Adrenal cortical carcinoma 
Adrenal cortical carcinoma is a rare malignant epithelial tumour of adrenal cortical cells 
(incidence about one case per million population per year) (Gicquel, Baudin, Lebouc, & 
Schlumberger, 1997)(Dackiw, Lee, Gagel, & Evans, 2001). About 80 % of the tumours are 
functional (mainly glucocorticoid or androgen excessive secretion). Distinguishing adrenal 
cortical carcinoma from adrenal cortical adenomas can be difficult. There are a number of   32
classifications predicting malignant behaviour. A modification of the Weiss criteria has been the 
most widely used. This is based on nine histopathological criteria: 
1.  High nuclear grade 
2.  >5 mitoses per 50 high-power fields 
3.  Atypical mitotic figures 
4.  <25% of tumour cells are clear cells 
5.  Diffuse architecture (>33% of tumour) 
6.  Necrosis 
7.  Venous invasion (smooth muscle in wall) 
8.  Sinusoidal invasion (no smooth muscle in wall) 
9.  Capsular invasion  
The presence of three or more criteria highly correlates with subsequent malignant behaviour 
(Weiss, 1984)(Aubert et al., 2002).  
1.7.3 Phaeochromocytoma 
A phaeochromocytoma is a tumour of chromaffin cells of the adrenal medulla (Figure 1.6). Most 
phaeochromocytomas are sporadic. However, increasing evidence suggests up to 24% of 
patients have a hereditary basis for phaeochromocytoma (Bauters et al., 2003). Genetic 
syndromes at increased risk of phaeochromocytoma include: multiple endocrine neoplasia type 
2, von Hippel Lindau syndrome or neurofibromatosis type 1. Phaeochromocytomas are usually 
associated with excess production of catecholamines. Excess catecholamine production is 
detected by measurement of increased levels of urine or plasma concentration of 
catecholamines or their metabolites. 
Malignant phaeochromocytomas are defined by the presence of metastatic disease. This 
definition does not account for those tumours with malignant potential. Therefore, a series of 
histological criteria such as vascular invasion, atypical mitotic figures or capsular invasion have   33
been identified to detect those patients with potentially malignant phaeochromocytomas (van 
der Harst et al., 2000)(L. D. Thompson, 2002)(Linnoila, Keiser, Steinberg, & Lack, 1990). 
However, several studies evaluating the criteria have reached differing conclusions. Unless 
metastatic disease is present, it is only possible to report the malignant potential. Therefore, 
until a test can accurately predict malignant behaviour all patients should be followed lifelong 
for hormonal assessment and repeat imaging to detect metastatic disease or local recurrence. 
Figure 1.6 Transverse section of a large phaeochromocytoma (scale in cm) 
 
1.7.4 Adrenal soft tissue and germ cell tumours 
These tumours can be benign or malignant arising from components of the adrenal gland other 
than steroid producing or catecholamine producing cells. Benign tumours include myelipoma, 
haemangioma, leiomyoma, schwannomas, ganglioneuromas or teratomas. Malignant tumours 
include leiomyosarcoma, angiosarcoma, malignant peripheral nerve sheath tumours and 
melanoma. 
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1.7.5 Adrenal metastases 
Adrenal metastases are defined as tumours that originate in extraadrenal locations and spread 
to the adrenal gland by metastasis. The most common primary sites were breast, lung, kidney, 
stomach, pancreas, ovary and colon. Adrenalectomy may prolong survival in a highly selective 
group of patients with solitary adrenal metastatic disease (Kim, Brennan, Russo, Burt, & Coit, 
1998b)(Paul, Virgo, Wade, Audisio, & Johnson, 2000). This has been reported for patients with 
adrenal metastases originating from colorectal carcinoma, lung carcinoma, renal carcinoma 
and melanomas. The role of LA for these patients is controversial as some authors feel a 
preoperative diagnosis of malignancy is a contraindication to laparoscopy.   
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1.8 Adrenalectomy 
1.8.1 Open versus laparoscopic adrenalectomy 
Open adrenalectomy (OA) either by the transabdominal, thoracoabdominal or lumbar approach 
can cause a number of post operative problems. These include: pain, respiratory complications 
or prolonged hospital stay. Following the success of laparoscopic cholecystectomy, 
laparoscopic adrenalectomy (LA) was first introduced in an attempt to reduce the morbidity 
associated with the open procedure. LA was first described by Gagner et al in 1992 (Gagner, 
Lacroix, & Bolt, 1992). They described a successful anterior transabdominal approach in 3 
patients (Cushing’s syndrome, Cushing’s disease and a phaeochromocytoma). The authors felt 
that LA may reduce morbidity, reduce analgesic requirements and reduce post operative stay 
when compared to OA. 
Since this time, multiple case-control studies have consistently demonstrated the benefits of LA 
compared OA in terms of blood loss, analgesic requirements, post operative complications, 
hospital stay and earlier return to normal activity for a variety of adrenal gland pathologies. 
Table 1.5 gives an overview of outcomes for studies comparing LA versus OA. 
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Table 1.5 Outcomes for laparoscopic adrenalectomy versus open adrenalectomy  
Author  Year  No. of patients 
 
LA               OA 
Blood loss 
(mls)* 
LA               OA 
Analgesia 
requirements 
(LA versus OA) 
Complications 
(%) 
LA               OA 
Length of stay 
(days)* 
LA               OA 
(Brunt et al., 
1996))  
1996  24                42  104             387  Reduced analgesia 
requirement 
17               64  3.2              7.5 
(MacGillivray, 
Shichman, 
Ferrer, & 
Malchoff, 1996)  
1996  17                12  198             500  n.a 
 
21               56  3                 7.9 
(Staren & Prinz, 
1996)  
1996  21                20  n.a.  n.a. 
 
n.a.  2.2              6.1 
(G. B. Thompson 
et al., 1997)  
1997  50                50  n.a.  Reduced analgesia 
requirement 
6                 72  3.1              5.7 
(Jacobs, 
Goldstein, & 
Geer, 1997)  
1997  19                19  109             263  n.a. 
 
5                 38  2.3              5.1 
(Linos et al., 
1997)  
1997  18                147  n.a.  Reduced duration of 
PCA use 
0                 12  2.2              6.3 
(Vargas et al., 
1997)  
1997  20                 20  245             283  Reduced analgesia 
requirement 
10               25  3.1              7.2 
(Winfield, 
Hamilton, Bravo, 
& Novick, 1998)  
1998  21                 17  183             266  Reduced analgesia 
requirement 
29               76  2.7              6.2 
(Ting, Lo, & Lo, 
1998)  
1998  12                 56  50               150  Reduced analgesia 
requirement 
0                 9  3                 5 
(Imai, Kikumori, 
Ohiwa, Mase, & 
Funahashi, 
1999)  
1999  40                 40  40               172  Reduced analgesia 
requirement 
5                 50  12              18 
(Dudley & 
Harrison, 1999)  
1999  36                 23  n.a.  n.a. 
 
6                 52  3.5              8.5 
(Soares, 
Monchik, 
Migliori, & 
Amaral, 1999)  
1999  12                 7  132             278  Reduced analgesia 
requirement 
8                 0  2.1              5.4 
(Schell, Talamini, 
& Udelsman, 
1999)  
1999  22                 17  n.a.  n.a. 
 
n.a.  1.7              6.7 
(Shen et al., 
1999)  
1999  42                 38  n.a.  n.a. 
 
0                11  n.a. 
(Rayan & Hodin, 
2000)  
2000  19                 48  n.a.  n.a. 
 
3                60  1.5              6.3 
(Hazzan et al., 
2001)   
2001  24                 28  n.a.  Reduced analgesia 
requirement 
16              39  4                 7.5 
(Ortega, Sala, 
Garcia, & Lledo, 
2002)  
2002  10                 10  n.a.  n.a.  10              30  3.7              5.8 
*Values are mean. LA, laparoscopic adrenalectomy;OA, open adrenalectomy;PCA, patient controlled analgesia;n.a., data not 
available 
 
Despite the lack of Level 1 evidence comparing LA with OA, it seems unlikely randomized 
controlled trials will be performed. This is primarily due to the benefits consistently 
demonstrated in favour of LA.   
Therefore, LA has become the procedure of choice for most adrenal gland pathologies. 
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1.8.2 Laparoscopic operative technique 
Laparoscopic approaches to the adrenal gland include the retroperitoneal approach, anterior 
transabdominal approach or the lateral transabdominal approach. 
The retroperitoneal approach was first described in 1995 (Mercan, Seven, Ozarmagan, & 
Tezelman, 1995) and subsequent series have since reported a safety and efficacy comparable 
to other laparoscopic approaches (Hanssen et al., 2006)(Bonjer et al., 2000)(Walz et al., 2006). 
Drawbacks to this approach include lack of familiarity amongst most general surgeons, limited 
working space and the unsuitability for resection of large adrenal tumours (≥6cm). Potential 
advantages are avoidance of the peritoneal cavity in patients with previous upper 
gastrointestinal surgery. From available studies, patient outcome remains similar compared to 
the lateral transabdominal approach for small-medium sized tumours.            
The anterior transabdominal approach is practised infrequently and therefore the evidence 
favouring this approach is scarce. The main reason for its unpopularity is the increased 
dissection, adjacent structure retraction difficulties and longer operating times compared to 
other procedures. 
The lateral transabdominal approach is the most popular approach in published case series. 
Reasons include: easiest to learn due to presence of an increased number of anatomical 
landmarks compared to the retroperitoneal approach and the ability to perform large adrenal 
tumour (≥6cm) resection. This was the favoured approach in the current series. This technique, 
initially described by Gagner, is described in detail. 
 
 
 
 
   38
1.8.3 Lateral transabdominal laparoscopic adrenalectomy 
Patient positioning 
The patient placed is in the lateral decubitus position with the operative side up. The table is 
broken to increase the space between the costal margin and iliac crest. 
Left side 
The port placements are illustrated in Figure 1.7. The middle port (10mm) is for a 30° camera 
and inserted using an open technique at a point just lateral to the rectus at the level of the 
umbilicus. Two instrument ports (5mm,5mm) are inserted under direct vision. One 5mm port is 
inserted parallel to the costal margin in the mid-clavicular line. The other 5mm port is inserted 
under the eleventh rib in the mid-axillary line. A further 5mm port is occasionally required to 
assist with splenic retraction. The splenic flexure of the colon and the lienorenal ligament of the 
spleen are mobilised using ultrasonic dissection. The colon can then be displaced inferiorly and 
the spleen displaced medially (Figure 1.8). This allows access to the adrenal gland. Dissection 
starts at the infero-medial aspect to allow early visualisation of the left adrenal vein (Figure 1.9). 
This is then divided between clips. The adrenal gland together with its surrounding fat are 
mobilised using ultrasonic dissection or electrocautery taking care not to breach the adrenal 
gland capsule. The adrenal gland is then removed via the camera port using a retrieval bag. 
The wound may require extension to allow retrieval. 
Figure 1.7 Port sites for left laparoscopic adrenalectomy. A 10 mm camera port and two (5mm) 
instrument ports are used 
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Figure 1.8 The lateral attachments of the spleen is mobilised allowing it to be displaced 
medially allowing access to the adrenal gland and adrenal vein 
 
 
Figure 1.9 The left adrenal vein is treble clipped and divided with harmonic scalpel. The 
adrenal gland is then completely mobilised 
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Right side 
The port placements are illustrated in figure 1.10. The camera port (10mm) is inserted just 
lateral to the rectus at the level of the umbilicus (30° laparoscope). Two 5mm instrument ports 
are placed as for the left side and a third is placed in the right iliac fossa. The most medial port 
is used to retract the right liver lobe. The right lobe of liver is mobilised from its lateral and 
posterior attachments and retracted (figure 1.11). This allows access to the adrenal gland and 
inferior vena cava. The lateral border of the inferior vena cava is dissected from the inferior part 
of the liver to the origin of the right renal vein. The main adrenal vein will be located between 
these points. After careful dissection the adrenal vein is divided between clips (figure 1.12). 
Care should be taken to ensure there is no duplicate adrenal vein. The adrenal gland together 
with its surrounding fat is then mobilised using ultrasonic dissection or electrocautery. The 
adrenal gland is removed via the camera port using a retrieval bag. The adrenal gland was not 
morcellated. 
 
Figure 1.10 Positioning and port placement for right laparoscopic adrenalectomy. On the right 
side a third instrument port (5mm) is used to allow liver retraction 
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Figure 1.11 The lateral attachments of the liver (arrow) are been divided to allow medial and 
superior mobilisation 
 
Figure 1.12 The lateral border of the inferior vena cava is dissected and the short main adrenal 
vein is identified 
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1.8.4 Technique modifications for larger adrenal tumours 
The laparoscopic technique was modified for large adrenal tumours. On the right side, initial 
dissection of the inferior vena cava and the adrenal vein is often impossible due to tumour size. 
We like other authors (Henry, Sebag, Iacobone, & Mirallie, 2002) start dissecting laterally, 
superiorly and inferiorly (often alternating between these sites). This progressive mobilisation 
then allows access to the inferior vena cava and the procedure continues as described above. 
Similarly, on the left, initial adrenal vein dissection may not be possible due to tumour size. 
Primary lateral, superior, inferior dissection and mobilisation allows access to the adrenal vein. 
Often, it is not possible to insert these large tumours into a retrieval bag. In these cases a 
wound protector is inserted and the tumour is removed directly through the wound. 
 
1.8.5 Uncertainty of laparoscopic adrenalectomy for large (≥6cm) potentially malignant 
tumours 
It is uncertain if the resection of large (≥6cm) potentially malignant adrenal tumours is 
appropriate due to concern over incomplete resection and local recurrence. Although LA for 
large adrenal tumours has successfully been performed with good oncological outcomes the 
results need to be interpreted with caution. Reasons for this include: selection for those suitable 
for laparoscopy was practised in many published series and patient numbers tended to be 
small or follow-up was not adequate. Table 1.6 shows the outcome of studies for the 
laparoscopic removal of large adrenal tumours. 
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Table 1.6 Laparoscopic adrenalectomy for large adrenal tumours 
Author LA≥6cm  
over 
Total LA* 
 
No of patients 
with 
malignancy° 
Tumour 
size 
(cm)† 
Conversion  Incomplete 
resection 
Local 
recurrence 
Mets  Follow-up† 
(months) 
 (Henry et al., 2002)    
19/233 
(8%) 
 
6 (6) 
 
7 (6-8) 
 
2 
 
0 
 
0 
 
1 
 
35 (17-59) 
 (MacGillivray, 
Whalen, Malchoff, 
Oppenheim, & 
Shichman, 2002) 
 
12/60 
(20%) 
 
3 (1) 
 
8 (6-12) 
 
0 
 
0 
 
0 
 
1 
 
24.5 (4-42) 
 (Walz et al., 2005)    
33/429 
(8%) 
 
6 (2) 
 
7.3 (2.1)¶ 
 
2 
 
n.a. 
 
2 
 
5 
 
n.a. 
 (Palazzo et al., 
2006)  
 
19/391 
(5%) 
 
3(3) 
 
6.5 (6-8) 
 
0 
 
n.a. 
 
1 
 
2 
 
25 (13-46) 
 (Soon et al., 2008)    
16/140 
(11%) 
 
3 (3) 
 
n.a. 
 
4 
 
n.a. 
 
0 
 
1 
 
18 (n.a.) 
 (Ramacciato et al., 
2008)  
 
20/107￿ 
(19%) 
 
4 (2) 
 
8 (7-9) 
 
3 
 
0 
 
0 
 
1 
 
n.a. 
 
* Values in parentheses are percentage of LA for tumours ≥6cm or ≥7cm in the case series 
￿ Tumours are 7cm or larger 
° Values in parentheses are numbers of primary adrenal cortical carcinomas 
† Values are median (IQR) 
¶ Value is mean (sd) 
n.a. , data not available 
  
 
 
 
 
 
 
 
 
 
 
 
   44
1.8.6 Laparoscopic subtotal adrenalectomy 
Laparoscopic subtotal adrenalectomy has emerged as a feasible option allowing either bilateral 
adrenal medulla resection or partial adrenal cortex resection in patients with a single remaining 
adrenal gland (Hardy & Lennard, 2008). Case series have reported the procedure is most 
strongly indicated in patients with bilateral phaeochromocytoma (familial) or patients with 
aldosterone or cortisol producing tumours who have had previous contralateral adrenalectomy. 
This has been shown to preserve endogenous steroid production and allow independence from 
oral steroid therapy in the majority of patients (Brauckhoff et al., 2003). 
Selection for subtotal adrenalectomy has generally been performed in small, well 
circumscribed, peripherally located lesions. Concern exists if the main adrenal vein is divided 
this may result in a non-functioning adrenal remnant. 
It remains unclear from the literature, the true incidence of this procedure compare as totality of 
adrenalectomy practice is rarely reported.  Results from small studies have reported no 
incomplete resections or local recurrences (follow-up range:3 months – 3 years) (Walz et al., 
1998)(Kok & Yapp, 2002). 
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1.8.7 Open adrenalectomy 
LA has become the procedure of choice for most adrenal pathologies but few have 
documented the incidence or outcomes of open adrenalectomy within a laparoscopic series. 
Therefore the results of open adrenalectomy in the laparoscopic era are unclear.      
The open approaches to the adrenal gland include: posterior (extraperitoneal), flank 
(extraperitoneal), transabominal or thoracoabdominal.  
For the posterior approach the patient is placed in the prone jackknife position. A hockey stick 
incision is made over the twelfth rib. The eleventh and twelfth ribs are often resected 
extrapleurally to allow access. The perinephric fat is swept away from the paraspinal 
musculature and the adrenal tumour is resected in an extraperitoneal manner. On the right the 
liver (within the peritoneum) is dissected off the anterior surface of the adrenal. A chest drain 
may be required if the pleura is breached. Disadvantages include restricted access. This 
technique is only suitable for small lesions.   
An alternative extraperitoneal technique is the flank approach. The patient is placed in the 
lateral position (adrenal pathology uppermost) and the table is broken to allow increased space 
between the costal margin and iliac crest. An incision is made over the 11th or 12th rib and the 
relevant rib is resected. The dissection continues as for the posterior approach. Advantages 
include improved access compared to the posterior approach. Disadvantages include inability 
to perform abdominal exploration or adjacent structure resection in the presence of local 
invasion (other than kidney). 
The transabdominal approach is by a midline or subcostal incision. The right adrenal is 
approached after Kocher’s mobilization of the duodenum. On the left access is gained by 
dividing the lienorenal ligament and Toldt’s fascia and sweeping the viscera forward. The 
advantages of this approach include resection of adjacent organs in the presence of local   46
invasion and bilateral adrenalectomy can be performed without changing patient position or 
utilising a separate incision.  
The thoracoabdominal approach provides the best access for very large adrenal tumours or 
where wide resection of adjacent organs is anticipated. The thoracoabdominal 9th or 10th rib 
approach is used. 
 
In the present series, the only contraindications to the laparoscopic approach were radiological 
locally advanced adrenal tumours requiring en-bloc resection of adjacent organs or the 
requirement of an additional open procedure. Therefore, in our series, the transabdominal or 
thoracoabdominal approach was felt to be the open technique of choice. 
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2 Summary and aims for the present work 
2.1 Summary 
1. The adrenal gland vasculature has been studied in a number of cadaver studies. However, 
the studies were carried out on non-diseased adrenal glands. It is not known if adrenal 
tumours, because of angiogenesis or vasodilatation of pre-existing vessels, may increase the 
variability of venous drainage and the number of periadrenal vessels. 
 
2. After subtotal adrenalectomy, a satisfactory blood supply to the adrenal remnant is vital to 
preserve function. It is not clear from the literature whether a preserved main adrenal vein is 
essential for remnant function. Nor is it clear, at time of surgery, that excessive mobilisation 
would destroy the arteries surrounding the adrenal gland and lead to an ischaemic, non-
functioning adrenal remnant.   
 
3. Few studies have compared the perioperative haemodynamic variables for laparoscopic 
adrenalectomy for phaeochromocytoma resection and other adrenal tumours. 
 
4. The role of laparoscopic adrenalectomy for large adrenal tumours (≥6cm) is controversial 
due to concerns over incomplete resection and local recurrence. As a result many surgeons opt 
for an open approach. 
 
5. There is currently little information on the results of open adrenalectomy in the laparoscopic 
era as totality of adrenalectomy practice is rarely reported. 
 
6. Due to the rarity of isolated adrenal metastasis, little is known about the role of laparoscopic 
adrenalectomy in this highly select group of patients.   48
2.2 Aims of thesis 
The aims of the present work are: 
1. To document the surgical importance of variable vein anatomy and multiple periadrenal 
vessels during the excellent magnified view experienced with laparoscopic adrenalectomy. 
 
2. To review the importance of the adrenal gland blood supply when performing a laparoscopic 
subtotal adrenalectomy.  
     
3. To look at the perioperative haemodynamic changes in patients undergoing laparoscopic 
adrenalectomy for phaeochromocytomas and other adrenal tumours. 
 
4. To assess the role of laparoscopic adrenalectomy for adrenal tumours of 6cm or greater. 
 
5. To assess the outcomes of open adrenalectomy in a consecutive series of patients referred 
with adrenal tumours. 
6. To assess the role of laparoscopic adrenalectomy for isolated adrenal metastasis. 
 
2.3 Database 
The data of consecutive patients referred for adrenalectomy were extracted from a 
computerised database from January 1999 – January 2009. This data included patient name, 
date of birth, unit number and tumour characteristics (which included abnormal main venous 
drainage). All adrenalectomies were performed by a single surgeon (PJOD). The database was 
maintained by PJOD. 
Case notes were then reviewed to extract additional patient data which included: patient 
physiology and follow-up.    49
3 Experience in identifying the venous drainage of the adrenal gland during 
laparoscopic adrenalectomy 
3.1 Introduction 
The venous drainage from each adrenal gland, described in standard anatomical textbooks, is 
usually via a single vein: the right one to join the inferior vena cava (IVC) and the left one to join 
the left renal vein (Gray & Williams, 1989). Variations to this pattern have been documented in 
a number of cadaver studies (Table 3.1). 
Table 3.1 Variability of main venous adrenal drainage 
 
Author 
(year) 
Number 
of cadavers 
Standard venous  
drainage 
Right side  
Variable venous 
drainage 
Right side  
Standard venous  
drainage 
Left side  
Variable venous  
drainage 
Left side  
 
 (Anson & 
Caudwell, 1948)  
 
450 
 
450  
 
0  
 
449  
 
1  
 (Johnstone, 
1957)  
 
10 
 
8 
 
2 
 
9 
 
1 
 (Clark, 1959)    
16 
 
 9 
 
7 
 
11  
 
5  
(Mikaelsson, 
1970) 
 
22 
 
22 
 
0 
 
22 
 
0 
 (El-Sherief, 
1982)  
 
20 
 
14 
 
6 
 
20 
 
0 
 (Monkhouse & 
Khalique, 1986)  
 
57 
 
27 
 
18 
 
57 
 
0 
* 12 right adrenal glands not suitable for dissection 
 
(Anson & Caudwell, 1948),  in a study of 450 cadavers, confirmed the constant venous 
drainage. It was not clear from this study of kidney and adrenal gland blood supply, if the main 
adrenal vein was dissected in all cadavers or if a more selective policy was used. However, 
results of subsequent cadaver studies which focused on the venous drainage in normal adrenal 
glands described increased variability of the main venous drainage (particularly on the right 
side) and a network of veins surrounding the adrenal gland (Johnstone, 1957)(El-Sherief, 
1982)(Monkhouse & Khalique, 1986). The variability in terms of duplication, triplication and 
termination of the main adrenal veins were described in these studies. The arterial supply of   50
the adrenal glands has been well documented. (Anson & Caudwell, 1948),  described the 
arterial supply of the adrenal glands, in that they can receive up to 60 rami (small arteries) 
derived from aorta, inferior phrenic and renal arteries. 
 
Since it was first introduced in 1992 (Gagner et al., 1992), laparoscopic adrenalectomy (LA) 
has become the procedure of choice for most adrenal pathologies. During LA, early 
identification and ligation of the main adrenal vein is an important step (Gagner, Pomp, 
Heniford, Pharand, & Lacroix, 1997). This is mainly to help orientation and prevent excessive 
haemorrhage.  
The cadaver studies mentioned above were performed on non-diseased adrenal glands. It is 
not known if adrenal tumours, due to angiogenesis or vasodilatation of pre-existing vessels, 
may increase both the variability of venous drainage and the number of periadrenal vessels. 
The purpose of this study was to document the importance of variable adrenal vein anatomy 
and the multiple periadrenal vessels during LA. 
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3.2 Methods 
A retrospective review of our own consecutive laparoscopic adrenalectomy series was 
performed (January 1999 – January 2009). Details of the main adrenal veins and any 
periadrenal vessel variant had been recorded in each operation note. During laparoscopy, the 
main adrenal veins were identified and then divided between liga-clips. Other periadrenal 
vessels were divided using electrocautery or ultrasonic dissection (use of ultrasound to cut or 
coagulate vessels).  
Preoperative information included: patient demographics and diagnosis. Intraoperative 
information included: details on the main venous drainage, any variant arterial or venous 
anatomy and any bleeding complications. Postoperative data included any further bleeding 
complications and the requirement for intervention. 
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3.3 Results 
Over the ten year period, 176 laparoscopic adrenalectomies (LA) were performed on 156 
consecutive patients (17 bilateral procedures, 3 patients delayed contralateral procedure).   
Of the 176 LA, the main adrenal vein was identified in all cases at time of laparoscopy. For 170 
LA, the main venous drainage was constant via a single vein (the right adrenal vein into the 
IVC and the left adrenal vein into left renal vein).  
For the other six patients, the main venous drainage was variable. Characteristics of the 
patients with a variable venous pattern are shown in Table 3.2. 
Table 3.2 Characteristics of patients with variable venous drainage 
Patients  Side  Pathology  Size  
(mm)  
Type of variability   Blood 
loss  
(mls)  
Type of bleeding 
problems  
 
1  
 
Right  
 
Phaeo  
 
80  
 
2 adrenal veins into IVC  
 
200  
 
Large tumour ooze from 
periadrenal vessels  
 
2  
 
Left  
 
Phaeo  
 
30  
 
1 adrenal vein into left renal 
vein  
1 adrenal vein unclear site of 
drainage  
 
Minimal  
 
None  
 
3  
 
Left  
 
Phaeo  
 
80  
 
2 adrenal veins into left renal 
vein  
 
Minimal  
 
None  
 
4  
 
Left  
 
Phaeo  
 
55  
 
2 adrenal veins into left renal 
vein  
 
Minimal  
 
None  
 
5  
 
Right  
 
ACC  
 
150  
 
1 adrenal vein into IVC  
1 adrenal vein into right renal 
vein  
 
Minimal  
 
None  
 
6  
 
 
Left  
 
Phaeo  
 
70  
 
2 adrenal veins into left  
renal vein   
 
Minimal  
 
None  
ACC = adrenocortical carcinoma, Phaeo = phaeochromocytoma 
 
In each case the main adrenal vein was duplicated. In 5 out of the 6 patients the two veins 
were clearly visualised draining into the left renal vein, right renal vein or inferior vena cava at 
separate points. For the other patient with a left sided phaeochromocytoma, the drainage of the 
second adrenal vein was unclear.    There were no bleeding complications due to failure to 
identify or ligate the adrenal vein variants. Of the six patients, only one had measurable blood   53
loss (200mls). This patient had a large (8cm) phaeochromocytoma with persistent ooze from 
the multiple periadrenal vessels. Conversion to an open procedure was performed due to 
concern over adjacent structure invasion. There were no other converted procedures for 
patients with variable adrenal vein drainage. The patient with a right adrenocortical carcinoma 
had a prominent, dilated second adrenal vein draining into the right renal vein. This has been 
illustrated by a magnetic resonance image (MRI) (Figure 1). 
Figure 3.1 Magnetic resonance image to illustrate duplicate adrenal vein for a patient with a 
large adrenal tumour 
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The characteristics of phaeochromocytomas with variable venous drainage compared to those 
with standard venous drainage are shown in Table 3.3. 
 Table 3.3 Characteristics of patients with phaeochromocytomas 
Characteristic 
 
Variable venous drainage  Standard venous drainage 
 
Type of secretion 
 
   Epinephrine 
   Norepinephrine 
   Dopamine 
   Epinephrine/Norepinephrine 
   Epinephrine/Norepinephrine/Dopamine 
   Catecholamine metabolites* 
   No secretion 
 
 
 
2 
1 
0 
0 
0 
2 
0 
 
 
 
6 
7 
1 
8 
5 
6 
1 
 
 
Size (maximum diameter, mm)† 
 
 
66 (33-75) 
 
 
50 (34-59) 
* Defined as elevation of urinary methoxy-derivatives or vanillyl mandelic acid  
† Median (interquartile range) 
 
Both groups secreted a range of catecholamines. The median size of the phaeocromocytomas 
with adrenal vein variants was 66mm (IQR33-75) compared to a median of 50mm (IQR34-59) 
for those with standard venous drainage.   
During laparoscopy, apart from the main adrenal vein, a high number of other small vessels 
were always present around the adrenal gland. It was not possible to differentiate between 
veins and arteries. These were all dealt with in the same way, by diathermy or ultrasonic 
dissection.  Due to the small size of these vessels there was no requirement to perform other 
haemostatic techniques. No laparoscopic procedure required conversion due to bleeding from 
these smaller vessels. For four patients with large (≥6cm) phaeochromocytomas (n=3) and an 
adrenal metastatic deposit secondary to renal cell carcinoma (n=1) there were increased 
number of periadrenal vessels. These were all divided without incident by careful ultrasonic 
dissection. The main venous drainage was by a single vein for these patients. In one patient 
with a phaeochromocytoma, the patient initially looked to have a duplicated left adrenal vein. 
As dissection progressed the second vein was found to travel into perinephric fat without 
obvious communication with the phaeochromocytoma.          55
3.4 Discussion 
The majority of patients (97%) undergoing LA had constant venous drainage. This was via a 
single vein draining into the inferior vena cava on the right and draining into left renal vein on 
the left. When variation did occur, the main vein was duplicated. Other multiple, small 
periadrenal vessels were noted at time of laparoscopy for all patients. It was not possible to 
distinguish between small veins and arteries. The small periadrenal veins which do exist may 
provide alternative venous drainage pathways. However, in the current study, they did not 
cause any surgical significance as they were all divided easily using electrocautery or 
ultrasonic dissection.  
 
Laparoscopy allows an excellent, magnified view (2.5-3 times normal) of the adrenal gland and 
surrounding structures compared to the traditional view seen at open surgery. Despite these 
advantages, it is not known if laparoscopy allows an accurate view of the venous anatomy. 
Identification of the main adrenal vein is an essential part of LA (Gagner et al., 1997). This 
study has demonstrated the main venous drainage (including variants) can be clearly defined 
at time of LA for all cases. No bleeding complications or the requirement to convert to an open 
procedure resulted from failure to recognise the main adrenal vein and its variants. 
 
A number of series have dissected adrenal veins in cadavers (Anson & Caudwell, 
1948)(Johnstone, 1957)(Clark, 1959)(El-Sherief, 1982)(Monkhouse & Khalique, 1986). In all 
these series there was no adrenal gland pathology.  In a large series of 450 cadavers, Anson et 
al. looked at the pararenal system of veins and arteries and commented on the constant nature 
of the venous drainage of the adrenal gland via a single vein. Only one variation occurred, 
where the left adrenal vein joined the right renal vein. There was no mention of duplication or 
triplication of the adrenal vein. However, it is not clear if the authors performed selected adrenal   56
vein dissection as the study did not specifically examine the venous drainage of the adrenal 
gland. There was also no mention of the network of smaller veins surrounding the adrenal 
gland. Therefore, this description of adrenal gland venous drainage should be interpreted with 
caution. 
Subsequent series focused on venous drainage and highlighted the variable nature, particularly 
on the right side (Table 1). However, compared to Anson et al. (1948), the numbers in these 
series were much smaller (Johnstone, 1957; Clark, 1959; El-Sherief, 1982; Monkhouse et 
al.,1986). In these series, using fresh or embalmed cadaver material, variability on the right 
side was fairly constant, occurring in 20-40% of cases. The variability involved duplication or 
triplication of the main vein. Also alternative venous drainage occurred into the hepatic or renal 
veins rather than the inferior vena cava. Johnstone (1957), described for 2 out of 10 cadaver 
dissections, the right adrenal vein draining directly into a right hepatic vein close to its junction 
with the inferior vena cava.   Variability on the left side appeared to be infrequent in the majority 
of series. Clark (1959) and Johnstone (1957) commented on a duplicated left adrenal vein. 
Clark (1959) described 5 out of the 16 cadavers having duplication of the main vein with both 
draining into the left renal vein and Johnstone (1957), one out of 10 dissections had a second 
main vein draining into a left lumbar vein. 
In the current series a variable main adrenal vein was infrequent. The single main left adrenal 
vein is in agreement with the majority of other studies. However, when variation did occur, this 
was by a duplicated adrenal vein. This has been previously described by Clark (1959) and 
Johnstone (1957). The infrequent variability of the main right adrenal vein was in contrast to 
previous studies which focused on adrenal venous drainage. When variation did occur this was 
as a duplicated vein as previously described by Johnstone, 1957; Clark, 1959; El-Sherief, 
1982; Monkhouse et al.,1986.    
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The presence of multiple periadrenal vessels has been well described in a number of 
anatomical studies. Johnstone (1957), in a series of 10 cadaver dissections, described multiple 
venules surrounding the adrenal gland and their drainage pattern. The venules could drain into 
the main adrenal vein, the perirenal fat veins, renal vein, inferior phrenic vein or lumbar vein.  
Anson et al. (1948) described the abundant arterial supply of the adrenal glands. They 
demonstrated up to 60 branches derived from the inferior phrenic, aorta or renal arteries can 
supply the adrenal gland. Folkman (1995), described the necessity of angiogenesis to allow 
tumour growth and then metastasize. Therefore, in the presence of an adrenal tumour, new 
periadrenal vessels could sprout from pre-existing vessels, which may lead to troublesome 
bleeding at time of laparoscopic adrenalectomy. These changes should become more apparent 
as the tumour increases in size. Our study, demonstrated the abundance of vessels around the 
adrenal gland. The periadrenal vessels did not represent a problem in the majority of cases. 
The vessels were controlled with electrocautery or ultrasonic dissection. However, for three 
patients with large phaeochromocytomas (≥6cm) and one patient with an adrenal metastasis 
there were an increased number of periadrenal vessels. Another patient with a large 
adrenocortical carcinoma (15cm) had multiple prominent vessels, particularly a tortuous, dilated 
second adrenal vein draining into the right renal vein. It is unlikely the second adrenal vein 
developed due to tumour angiogenesis. A possible explanation could be compression of the 
main adrenal vein (due to the mass effect of the tumour) which caused preferred venous return 
down the second adrenal vein. 
 In the current study the adrenal vein variants all occurred in patients with 
phaeochromocytomas or a large (15cm) adrenocortical carcinoma. Out of 39 patients with 
phaeochromocytomas, only 5 showed variant venous anatomy. The range of catecholamine 
secretion was comparable to phaeochromocytomas with standard venous anatomy. This is the 
first study to describe main adrenal vein variants during LA for a series of patients with   58
phaeochromocytomas. Other series have described only standard venous anatomy during LA 
for phaeochromocytoma (Cheah, Clark, Horn, Siperstein, & Duh, 2002)(Gotoh, Ono, Hattori, 
Kinukawa, & Ohshima, 2002). 
 
Our study has demonstrated laparoscopic adrenalectomy can visualise the main venous 
drainage (and any variants) from the adrenal gland with minimal bleeding complications. This 
has helped confirm the constant nature of the main adrenal veins in the majority of patients 
undergoing laparoscopic adrenalectomy. However, adrenal vein variants and an increased 
number of periadrenal vessels appeared to occur in patients with phaeochromocytomas or 
large adrenocortical carcinomas. Increased care regarding the adrenal gland vasculature may 
be required during laparoscopic adrenalectomy for these patients. 
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4. Importance of the adrenal gland blood supply during laparoscopic subtotal 
adenalectomy 
4.1 Introduction 
Subtotal adrenalectomy was first described in 1934. Subtotal adrenalectomy allows either 
bilateral adrenal medulla resection or partial adrenal cortex resection in patients with a single 
remaining adrenal gland. The procedure has been performed in patients with a familial 
predisposition to phaeochromocytoma and patients with a cortisol or aldosterone producing 
adenoma who have had a previous contralateral adrenalectomy (Hardy & Lennard, 2008). 
Subtotal adrenalectomy has been shown to preserve endogenous steroid production and allow 
independence from oral steroid therapy in the majority of patients (Brauckhoff et al., 2003). The 
popularity of the procedure has been variable with only small series reported in the literature. 
Recently, improved preoperative imaging, excellent magnified views at time of laparoscopy and 
the use of ultrasonic dissection has resulted in increased number of patients to be considered 
for the procedure. It remains unclear from the literature the frequency of this procedure 
compared to the overall number of adrenalectomies performed as totality of practice is rarely 
reported. 
After subtotal adrenalectomy, a satisfactory blood supply to the adrenal remnant is vital to 
preserve function (Ikeda et al., 2001). It is not clear from the literature whether a preserved 
main adrenal vein is essential for remnant function. Nor is it clear, at time of surgery, that 
excessive mobilisation would destroy the arteries surrounding the adrenal gland and lead to an 
ischaemic, non-functioning adrenal remnant.   
The aim of the current study was to review the importance of the adrenal gland blood supply 
when performing a laparoscopic subtotal adrenalectomy.      
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4.2 Methods 
The blood supply of the adrenal gland was examined in three ways. 
An overview of the adrenal blood supply was studied in cadaver dissections. This involved a 
computer-assisted search of Medline database. The combinations and terms included: 
adrenal/suprarenal blood supply, adrenal/suprarenal arteries, adrenal/suprarenal veins and 
adrenal vein variants. The results have been summarised in Chapter 3 (Table 3.1). 
     
A review of our own consecutive laparoscopic adrenalectomy series was performed (January 
1999 – January 2009). The details of the main adrenal veins and variants had been recorded in 
each operation note. The results have been summarised in Chapter 3. 
 
Cadaver dissection of adrenal glands was performed. The dissected cadavers were from 
Glasgow University Anatomy department. The arterial and venous supply was examined. The 
adrenal arteries were initially injected with latex/India ink mixture via the carotid artery. The 
adrenal gland and its surrounding tissue were cleared using the Spaltehoz technique (a 14 day 
technique using alcohol and then methyl salicylate in the final step). Photography was 
performed using a Wolfvision LB9 visualiser (WolfVision). The venous supply was examined 
using standard dissection and then histological techniques. A modified Masson’s trichrome 
stain was used for microscopy. 
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4.3 Results 
Literature overview 
The main venous drainage described in cadaver studies has given differing results (Table 3.1). 
On the left side the adrenal gland appeared to be drained by a single main vein in the majority 
of the studies. Only Clark, 1959, in his study of 16 non injected cadavers, found duplication of 
the main left adrenal vein in 5 cases. On the right side, much more variation of the main 
adrenal vein was found. The main variants were duplication or triplication of the main adrenal 
vein. 
Johnstone, Mikaelsson, El-Sherief and Monkhouse described the presence of smaller veins 
surrounding the adrenal gland (particularly on the lateral aspect). The nomenclature of these 
smaller veins varied: peripheral, capsular or superficial. Using venous contrast, Mikaelsson, 
1970, described how these peripheral veins originated from the adrenal gland rather than the 
surrounding capsule or perirenal fat.  
Arterial blood supply was found to be remarkably consistent between the cadaver studies. The 
arteries supplying the adrenal gland took their origin from the following sources: inferior phrenic 
artery, aorta and renal artery. All authors described multiple small arteries surrounding and 
entering the gland. Anson et al. (1948), describe 50-60 small arteries supplying the adrenal 
gland.   
 
Adrenal vein variants visualised at time of laparoscopic adrenalectomy 
Over the ten year period, details of the main adrenal vein and any variants have been 
documented in the results section of Chapter 3. During laparoscopy, apart from the main 
adrenal vein, a high number of other small vessels were always present around the adrenal 
gland. It was not possible to differentiate between veins and arteries. 
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Cadaver dissection 
Arterial supply 
4 adrenal glands with intra-arterial latex were cleared of periadrenal fat using techniques 
described in the methods section. There were 2 left sided and 2 right sided glands. The arteries 
originated from the inferior phrenic artery, the aorta and the renal artery. Division occurred in 
the fat surrounding the adrenal gland. The large number of small arteries surrounding and 
entering the adrenal glands are demonstrated in Figure 4.1. 
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Figure 4.1 The images show semi-cleared adrenal glands. A is a left adrenal gland. B shows a 
right adrenal gland. Arterial vessels are seen in black due to latex/Indian ink injection 
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Venous drainage 
The venous drainage was studied in 4 adrenal glands (2 left and 2 right). Using standard 
dissection techniques, the main venous drainage was via a single vein: the right one to join the 
inferior vena cava and the left one to join the left renal vein. However, a large number of 
smaller peripheral veins follow the numerous arteries surrounding the adrenal gland. These 
vessels leaving the lateral aspect of a left adrenal gland are demonstrated in Figure 4.2. 
Figure 4.2 Dissection of lateral surface of the adrenal gland 
                 AG, left Adrenal Gland. Peripheral veins (veins are white, arteries are black) 
 
 
 
These lateral placed veins were studied on histological slides to ensure they were actually 
draining the gland rather than running along the surface. Microscopic examination was 
performed in 2 cases (one left and one right). This confirmed the veins drained the lateral 
aspect of the gland. Figure 4.3 demonstrates a peripheral situated vein progressively leaving 
the gland on repeated sectioning. 
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Figure 4.3– Five sections (I-V) 
showing a central vein (c) in the 
medulla  (I) which is drained by a 
superficial vein (v) penetrating the 
capsule (IV), into the perinephric fat 
(V). 
v 
v
c 
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4.4 Discussion    
Laparoscopic subtotal adrenalectomy is becoming an attractive option in certain patients with 
adrenal pathologies (eg familial phaeochromocytomas, aldosterone producing adenomas, 
cortisol producing adenomas). This can eliminate the need for hormone substitution in the 
majority of patients. Adequate arterial supply and venous return is essential to allow a resulting 
functioning adrenal remnant for patients undergoing subtotal adrenalectomy. 
This study has shown from our own and previous cadaver dissection multiple small arteries 
completely surround the adrenal gland. The main adrenal vein was remarkably constant. 
However, when variation does occur this was usually duplicated or triplicated. In addition to the 
main adrenal vein, cadaver studies have shown a network of peripheral veins surround the 
adrenal gland. These veins were closely related to the arteries. 
From the small series describing subtotal adrenalectomy it was not clear whether preservation 
of the main adrenal vein was essential to allow subsequent adrenal remnant function. Imai et al 
described laparoscopic subtotal adrenalectomy in 5 patients (aldosterone producing adenoma 
or weak functioning adrenocortical adenoma) with preservation of the main adrenal vein (Imai 
et al., 1999). The authors’ hypothesised preservation of the main vein was essential to avoid 
venous congestion which would lead to a non-functioning remnant. The resultant function of the 
adrenal remnant was not reported. Roukounakis et al, reported the importance of adrenal vein 
preservation for 7 patients undergoing subtotal adrenalectomy for aldosterone producing 
adenomas or myelolipomas. Again, details of post-operative adrenal function was not reported 
(Roukounakis et al., 2007). (Janetschek et al., 1998), described subtotal adrenalectomy in 6 
patients with inherited phaeochromocytoma. In a mean follow-up of 18 months there were no 
recurrences. The authors felt preservation of the main vein was essential to allow for a 
functioning adrenal remnant.   67
Ikeda et al felt the adrenal vein could be divided without consequence to the adrenal remnant 
(Ikeda et al., 2001). They described subtotal adrenalectomy with main vein division for 6 
patients (aldosterone producing adenoma, inherited phaeochromocytoma). Postoperative 
adrenal function was assessed by I-adosterol scintigrams. However, scintigraphy is not a 
suitable test to determine sufficient endocrine function. Brauckhoff et al, advocated a selective 
approach to division of the main adrenal vein depending on the site of the adrenal tumour 
(Brauckhoff et al., 2003). Of the 14 patients, 4 patients underwent bilateral subtotal 
adrenalectomy with division of the main adrenal vein. No patient required substitution with 
exogenous steroids. Postoperative adrenal function was assessed by serum levels of cortisol 
and adrenocorticotropic hormone (ACTH) within the normal range. Walz and colleagues 
demonstrated similar findings (Walz et al., 1998). Subtotal adrenalectomy was performed in 2 
patients with bilateral hereditary phaeochromocytoma. Postoperative cortisol levels were within 
the normal range. 
 
In Chapter 3 our laparoscopic study has shown the consistency of the main adrenal vein. 170 
out of 176 laparoscopic arenalectomies the main adrenal vein was single and originated from 
the same site. Duplication of the main adrenal vein occurred in 6 cases. A number of peripheral 
vessels always surrounded the gland. It was not clear at laparoscopy if these represented 
arteries or veins. Overview of cadaver studies assessing the venous drainage of the adrenal 
gland consistently demonstrated smaller veins surrounding the adrenal gland. Mikaelsson 
examined adrenal venous drainage in 22 fresh cadaver specimens (Mikaelsson, 1970). The 
cadavers had been injected with contrast into the vena cava. Using a combination of dissection 
and radiological examination the author demonstrated these peripheral veins drained the 
adrenal gland.    68
We have demonstrated using gross dissection and histological methods it was possible to 
follow the venous drainage from the adrenal gland to these peripheral veins. This has helped 
establish the peripheral veins drain the adrenal gland. 
Therefore, we support the findings of Brauckhoff and Walz, that division of the adrenal vein can 
be performed safely without causing venous congestion and non-functioning of the adrenal 
remnant. However, when the main adrenal vein is divided excessive mobilisation of the adrenal 
gland should be avoided due to concern the above mentioned peripheral veins may be 
destroyed and potentially result in a non-functioning adrenal remnant. 
 
It was clear from our cadaver dissection the adrenal gland is supplied by many small arteries 
which surround the gland. This is in agreement with (Anson & Caudwell, 1948). In their study of 
450 cadavers it was observed the adrenal gland is supplied by up to 60 small arteries 
originating from the aorta, inferior phrenic and renal arteries. Therefore, it would appear unlikely 
the adrenal remnant would become ischaemic due to inadequate arterial supply during subtotal 
adrenalectomy. Almost complete mobilisation of the adrenal remnant would be required to 
achieve this. 
 
Factors other than adrenal blood supply should also be considered to preserve adrenal 
remnant function. Selection is important as small, isolated, peripheral and well demarcated 
lesions are most suitable. Centrally placed lesions can make the procedure more demanding or 
in some cases impossible.  At initial dissection a decision is made to divide or preserve the 
adrenal vein. Careful mobilisation of the adrenal tissue containing the lesion is performed. 
Subtotal adrenalectomy is then performed using ultrasonic dissection. Using this technique, 
collateral damage to adjacent tissue is limited to less than 5mm. Alternatively, a vascular 
stapler can be utilised.  However, it is important to leave sufficient functioning adrenal remnant.   69
Brauckhoff and colleagues, in a series of 22 patients, recommended adrenal remnant size < 
25% of normal gland size should be avoided to prevent adrenal hypofunction. The authors 
used intraoperative ultrasound to determine normal adrenal tissue and identify the resection 
margins.     
Conclusion 
This study has helped show, during laparoscopic subtotal adrenalectomy, a non functioning 
adrenal remnant is unlikely due to an inadequate arterial supply. Division of the main adrenal 
vein can be performed safely without risk of venous congestion. However, once the main 
adrenal vein is divided, extensive mobilisation of the adrenal remnant should be avoided to 
prevent destruction of the smaller peripheral veins necessary for venous drainage. 
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5. Perioperative haemodynamic changes in patients undergoing laparoscopic 
adrenalectomy for phaeochromocytomas and other adrenal tumours 
5.1 Introduction 
Laparoscopic adrenalectomy (LA) has become a well established operation for 
phaeochromocytoma resection and results in improved hospital stay and shorter 
convalescence when compared to open adrenalectomy (Gagner et al., 1997)(Assalia & 
Gagner, 2004)(Fernandez-Cruz, Taura, Saenz, Benarroch, & Sabater, 1996). However, both 
pneumoperitoneum and adrenal gland manipulation have been shown to cause a high level of 
catecholamine release during laparoscopic resection (Joris et al., 1999) (Tauzin-Fin et al., 
2004). This can result in haemodynamic changes in the form of severe hypertension (systolic 
blood pressure (SBP) >200mmHg) and cardiac arrhythmias (Inabnet, Pitre, Bernard, & 
Chapuis, 2000)(Kinney et al., 2000). Subsequent removal of the adrenal gland results in a 
marked decrease in catecholamines and can induce hypotension which may be refractory to 
fluid or alpha agonist therapy (Prys-Roberts, 2000).  
A number of studies have documented the perioperative haemodynamic changes during 
phaeochromocytoma resection using a variety of regimens to control arterial blood pressure. 
For example, Kinney et al, studied 143 patients who received preoperative phenoxybenzamine 
(a long acting non selective alpha blocker). Despite this, 20 patients (14%) experienced very 
severe intraoperative severe SBP>220mmHg. Other regimens such as calcium antagonists are 
an alternative to phenoxybenzamine. Lebuffe et al used preoperative oral nicardipine, 27 out of 
105 patients (26%) experienced severe SBP>200mmHg, 12% experienced persistent 
hypotension and 30% experienced a tachycardia (heart rate>120bpm). However, in both of 
these studies only 3% and 22% (respectively) of patients underwent a laparoscopic procedure. 
In the current series, we used a phenoxybenzamine regimen and felt complete alpha blockade 
was achieved in all cases. As a result, we felt using this regimen and a specialist endocrine,   71
anaesthetic and surgical team the perioperative haemodynamic stability of LA for 
phaeochromocytoma has improved to such a degree that they may now be comparable to LA 
for other non-catecholamine secreting adrenal tumours. 
A small number of studies have compared the laparoscopic perioperative haemodynamic 
changes of phaeochromocytoma resection with other adrenal tumours (Gotoh et al., 
2002)(Weismann et al., 2006)(Kim, Brennan, Russo, Burt, & Coit, 1998a). Unfortunately, the 
numbers tended to be small or the laparoscopic technique was used infrequently. 
Therefore, the aim of the present study was to compare the perioperative haemodynamic 
changes in consecutive patients undergoing LA for phaeochromocytomas and other adrenal 
tumours during the same period.  
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5.2 Methods 
 
 
From January 1999 to January 2009, details of patients who underwent laparoscopic 
adrenalectomy were identified from a prospective database. Perioperative physiology 
parameters were obtained by performing a retrospective case note review. 
The diagnosis of phaeochromocytoma was based on clinical, biochemical and imaging studies. 
Clinical presentation included intermittent episodes of palpitations, sweating, headaches and 
hypertension. Patients from an affected family or genetic syndromes (eg MEN2 or von Hippel-
Lindau) were also screened. Biochemical screening included 24 hour urine collections for the 
measurement of fractionated catecholamines and their metabolites (metanephrines and 
vanillymandelic acid (VMA)). Localization of the tumour was by computed tomography (CT) or 
magnetic resonance imaging (MRI) scans. I-meta-iodo-benzylguanidine (MIBG) nuclear 
scanning was used to detect metastatic disease or extra-adrenal paraganglioma. These 
patients were called the phaeochromocytoma group. 
The diagnosis of other adrenal tumours was based on clinical findings and hormonal 
assessment. Localization of the tumour was by CT or MRI. These patients were called the non-
phaeochromocytoma group. 
At initial endocrine assessment, all patients with a suspected phaeochromocytoma received 
oral phenoxybenzamine as the primary alpha blocker (range 10-60mg/day). This was titrated to 
achieve a blood pressure measurement <160/90 mmHg. Patients, who were hypertensive, 
were often taking other anti-hypertensive medication, usually initiated by the referring physician 
prior to the diagnosis of phaeochromocytoma. This included: beta-blockers, ACE inhibitors, 
calcium antagonists and loop and thiazide diuretics. Patients were not routinely beta-blocked in 
the preoperative period. Hypertension was controlled in all phaeochromocytoma patients prior 
to elective resection. Patients who were hypertensive in the non phaeochromocytoma group 
received a variety of anti-hypertensives, again dependant on the referring physician, including:   73
beta-blockers, ACE inhibitors, calcium antagonists and loop and thiazide diuretics. Once a 
diagnosis of Conn’s syndrome was made, additional potassium-sparing diuretics were 
introduced (spironolactone or amiloride).  
All patients in the phaeochromocytoma group received an infusion of phenoxybenzamine (1mg 
kg-1, a non selective alpha blocker) the day before LA. Oral phenoxybenzamine was 
discontinued the day before theatre. 
General anaesthesia was performed by a single anaesthetist. The following technique was 
used: induction was with a combination of fentanyl, propofol and a muscle relaxant, and 
maintenance by volatile agents (isoflurane, sevoflurane) in an air/oxygen mixture and morphine 
as a bolus or infusion. Arterial blood pressure was monitored either by a radial arterial line or by 
a non-invasive oscillometric blood pressure cuff (measured every three minutes). Pulse and 
blood pressure measurements were recorded on to an anaesthetic chart every five minutes. 
Laparoscopic adrenalectomy was performed using the lateral transabdominal approach. During 
surgery for phaeochromocytoma, episodes of hypertension (SBP>180mmHg) were treated with 
intravenous phentolamine (boluses 1 to 2mg) and/or labetalol (boluses 5 to 10mg). 
Tachycardia was treated with intravenous labetalol (boluses 5 to 10mg). Hypotension was 
treated with fluid boluses (crystalloid or colloid) and/or an intravenous vasopressor 
(metaraminol). 
Preoperative information included age, sex, diagnosis, blood pressure measurement, 
antihypertensive medication and in the case of phaeochromocytomas the preoperative levels of 
urinary or plasma catecholamines. Intraoperative information included method of anaesthesia, 
total anaesthetic time, all pulse and blood pressure recordings, use of antihypertensives, use of 
intravenous fluids or blood products and operative complications. Postoperative information 
included recovery room haemodynamic measurements, the use of vasopressors and the 
requirement of intensive care admissions.    74
Severe hypertension was defined as SBP >200mmHg (Inabnet et al., 2000)(Gotoh et al., 
2002)(Sprung et al., 2000)  . A transient episode was defined as <10minutes and a persistent 
episode was defined as >10minutes.  Persistent tachycardia was defined as a heart rate 
>120bpm>10minutes (Lebuffe et al., 2005). Persistent hypotension was defined as SBP 
<80mmHg>10minutes (Lebuffe et al., 2005)(Kinney et al., 2000). 
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Statistical analysis 
Categorical variables were compared using Chi-square and Fishers exact tests where 
appropriate. For continuous data median and interquartile range (IQR) or mean and range were 
calculated where appropriate. Analysis of continuous data was performed using the Mann-
Whitney test. A p value of <0.050 was assumed to be statistically significant. Analyses were 
performed using SPSS (Version 17.0). 
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5.3 Results 
Over the ten year period, 39 consecutive patients underwent 42 LA for phaeochromocytoma. 
Two patients underwent bilateral phaeochromocytoma resection for familial disorders (Von 
Hippel-Lindau and MEN 2B syndromes). Another patient underwent a delayed contralateral 
procedure for familial phaeochromocytoma. During the same period 117 consecutive patients 
underwent 134 LA for other adrenal tumours (non phaeochromocytoma). 15 patients 
underwent bilateral LA and 2 patients had a delayed contralateral procedure.  Patient 
characteristics are listed in Table 5.1. 
Table 5.1 Characteristics of 156 patients undergoing laparoscopic adrenalectomy 
 
 
  Phaeochromocytoma 
group 
Non phaeochromocytoma group 
 
 
Number of patients 
 
39 
 
117 
 
Sex ratio (M:F) 
 
16:23 
 
49:68 
 
Age* 
 
55 (29-84) 
 
57 (18-79) 
 
Preop heart rate (bpm)† 
 
77 (70-90) 
 
73 (63-82) 
 
Preop SBP (mmHg)† 
 
 
133 (117-152) 
 
139 (129-156) 
Preop=preoperative 
SBP = Systolic Blood Pressure 
*Values are mean (range) 
a3 patients had delayed contralateral adrenalectomy 
† Values are median (interquartile range) 
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Preoperative data 
The most commonly secreted catecholamines were epinephrine (n=8) and norepinephrine 
(n=8) (Table 5.2). One patient with a phaeochromocytoma was non-secreting on a background 
of multiple endocrine neoplasm (MEN) syndrome. 
Table 5.2 Type of catecholamine secretion observed in 39 patients with phaeochromocytoma 
 
Type of catecholamine secretion 
 
Number of patients  Subgroups which 
experienced intraoperative 
SBP 200-220mmHg 
 
Epinephrine 
 
8 
 
0 
 
Norepinephrine† 
 
8 
 
1 
 
Dopamine 
 
1 
 
0 
 
Epinephrine/Norepinephrine 
 
8 
 
3 
 
Epinephrine/Norepinephrine/Dopamine 
 
5 
 
3 
 
Catecholamine metabolites* 
 
8 
 
0 
 
Non secreting 
 
 
1 
 
0 
SBP= systolic blood pressure 
†One patient underwent delayed contralateral procedure (recurrent norepinephrine secretion) 
* Defined as elevation of urinary methoxy-derivatives or vanillyl mandelic acid 
 
All patients received oral phenoxybenzamine (range 10mg-60mg/day) at time of diagnosis. All 
patients with a phaeochromocytoma received an intravenous phenoxybenzamine infusion (1mg 
kg-1) the day before surgery. The preoperative blood pressure was controlled in all patients 
prior to surgery (Table 5.1). In the phaeochromocytoma group, 37 out of 40 procedures had 
invasive measurement of arterial pressure compared to 14 out of 119 patients in the non 
phaeochromocytoma group. 
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Intraoperative data 
Table 5.3 compares the intraoperative haemodynamic parameters between the two patient 
groups. 
Table 5.3 Table to show intraoperative events between patients with phaeochromocytomas  
and non phaeochromocytomas  
 
 
 
 
Intraoperative event 
 
 
Phaeo  
(Number of 
procedures=40) 
 
 
Non phaeo 
(Number of 
procedures=119) 
 
P value 
 
Transient severe hypertension 
(SBP>200mmHg <10 mins) 
No transient severe hypertension 
 
6 
 
34 
 
2 
 
117 
 
 
 
 
 
0.004 
 
 
  
 
Persistent severe hypertension 
(SBP>200mmHg >10 mins) 
No persistent severe hypertension 
 
2 
          
38   
              
 
1 
 
118 
 
 
0.317 
 
 
Antihypertensive treatment 
 
          22 2  <0.005 
Persistent tachycardia  
(HR >120bpm >10mins) 
No persistent tachycardia 
 
          2 
        
          38 
       
1 
 
118 
 
0.317 
Persistent hypotension  
(SBP<80mmHg >10mins) 
No persistent hypotension 
 
          3 
 
          37 
       
9 
 
110 
 
1.000 
 
 
Fluid requirements 
(litres)† 
 
1.5  
(1-2.0) 
1.5  
(1-1.5) 
0.114 
Total anaesthetic time for unilateral LA 
(minutes)† 
 
110  
   (85-150) 
100  
(80-130) 
0.375 
SBP=systolic blood pressure 
HR=heart rate 
† Values are median (interquartile range) 
 
Seven patients experienced severe hypertension (SBP>200mmHg) in the phaeochromocytoma 
group: transient episodes (n=5), transient with persistent episodes (n=1), persistent episode 
(n=1). One experienced a transient SBP >220mmHg. The main catecholamines secreted were:   79
norepinephrine, epinephrine and dopamine (n=3), norepinephrine and epinephrine (n=3) and 
norepinephrine (n=1).  These episodes were all controlled with phentolamine and labetalol. All 
patients who experienced severe hypertension were diagnosed with preoperative hypertension. 
Two patients in the non phaeochromocytoma group experienced SBP>200mmHg: transient 
episode (n=1), transient with persistent episodes (n=1). The patients had Cushing’s syndrome 
and a cortisol producing adrenocortical carcinoma (respectively). Intraoperative 
antihypertensive use was significantly increased in the phaeochromocytoma group (Table 5.3). 
Two patients in the phaeochromocytoma group developed a persistent sinus tachycardia. 
These episodes were treated successfully with labetalol. One patient with a non functioning 
adenoma developed a cardiac arrhythmia. There was no significant difference between groups 
for persistent hypotensive episodes. The intraoperative fluid requirement was not different 
between the two groups (p=0.114) (Table 5.3).  
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Recovery room data 
There were no persistent haemodynamic changes in the recovery room. Recovery room 
haemodynamic data is shown in Table 5.4. Two patients experienced transient hypotension 
(SBP<80mmHg) after phaeochromocytoma resection. One of these patients was treated with 
metaraminol. There was no perioperative mortality.  
Table 5.4 Table to show recovery room haemodynamic parameters between patients with 
                 phaeochromocytomas and non phaeochromocytomas 
 
 
Recovery room parameters 
 
 
Phaeo 
(number of 
operations=40) 
 
Non Phaeo 
(number of 
operations=119) 
 
P value 
 
Transient Hypotension 
(SBP<80mmHg) 
 
 
2 
 
2 
 
0.564 
Vasopressor treatment 
 
1 0  0.566 
Discharge pulse† 
 
75 (70-80)  75 (65-85)  0.984 
Discharge SBP 
(mmHg)† 
 
114 (105-126)  130 (120-145)  <0.005 
SBP=systolic blood pressure, at time of discharge from recovery 
HR=heart rate, at time of discharge from recovery 
† Values are median (interquartile range) 
 
 
 
 
 
 
 
 
 
 
   81
5.4 Discussion 
Laparoscopic adrenalectomy for phaeochromocytoma was associated with increased episodes 
of severe intraoperative hypertension when compared to the laparoscopic resection of other 
adrenal tumours. These episodes were all controlled with anti-hypertensive medication. There 
were no other significant differences in terms of hypotensive episodes, cardiac arrhythmias or 
intravenous fluid requirements. 
Phenoxybenzamine (a long acting, noncompetitive α adrenergic antagonist) has been the 
mainstay of preoperative treatment inhibiting the effects of excessive catecholamines during 
phaeochromocytoma resection (Bravo & Tagle, 2003). The pharmacological half life for 
phenoxybenzamine is about 24 hours. In an attempt to prevent prolongation of α blockade in 
the post-operative period, oral phenoxybenzamine is usually stopped 24-48 hours before 
surgery. Despite the documented benefits of oral phenoxybenzamine, severe intraoperative 
hypertension (SBP >200mmHg) can still occur. (Kinney et al., 2000), used only preoperative 
oral phenoxybenzamine, without an infusion the day before admission, in 127 out of 143 
patients undergoing phaeochromocytoma resection. 20 patients (14%) experienced very 
severe SBP >220mmHg (mean 9±9min). 117 out of 143 patients required intra-operative 
antihypertensive treatment. LA was only performed in 3% of patients. 
In our study, phenoxybenzamine was administered as an oral preparation in the 
phaeochromocytoma group at time of diagnosis. Unlike other studies, all the patients in the 
group received an intravenous preparation of phenoxybenzamine (1mg kg-1) the day before 
surgery. Using this regimen, there were no differences in terms of preoperative pulse and 
systolic blood pressure measurements between the two groups. Only one patient in the 
phaeochromocytoma group experienced transient very severe intraoperative hypertension 
(SBP >220mmHg <10 minutes). It is interesting to note that 6 of the 7 patients in the 
phaeochromocytoma group who experienced severe intraoperative hypertension had elevated   82
levels of both epinephrine and norepinephrine. This would suggest that the more problematical 
patients are those with a mixture of high alpha and beta agonism. Our regimen of 
comprehensive alpha blockade prevented persistent severe hypertension in all those secreting 
only norepinephrine. This would support the use of alpha antagonists as being the primary 
mechanism to modify, but there also needs to be attenuation of the extra alpha and beta 
agonism which results from epinephrine. 
A previous series demonstrated that pre-treatment with phenoxybenzamine prior to 
phaeochromocytoma resection resulted in persistent α-adrenoceptor blockade well into post 
operative period (Prys-Roberts & Farndon, 2002). After resection, this resulted in persistent 
arterial hypotension resistant to adrenergic arteriolar constrictors and large volumes of 
intravascular fluid. In an attempt to reduce post operative hypotension, Prys-Roberts et al. 
changed to a specific α1-adrenoceptor antagonist, doxazosin, instead of phenoxybenzamine, 
because it does not block presynaptic α2 mediated release of norepinephrine. The authors felt, 
there was no detectable adrenergic blockade in 25 patients receiving doxazosin (4mg/day) on 
the first postoperative day. 
Our series demonstrated no patient in the phaeochromocytoma group experienced persistent 
hypotension (systolic blood pressure <80mmHg >10 minutes) in the recovery room period. 
There was also no significant difference between groups for intraoperative intravenous fluid. 
Fluid balance assessment, fluid replacement therapy and intraoperative blood loss have 
improved since the series by Prys-Roberts, therefore relative hypovolaemia and hypotension 
should be less of a problem. 
The use of preoperative calcium antagonists as an alternative to phenoxybenzamine has been 
advocated to control blood pressure and symptoms for patients undergoing 
phaeochromocytoma resection (Lebuffe et al., 2005)(Proye et al., 1989). This regimen attempts 
to prevent the adverse effects of the prolonged α-blockade of phenoxybenzamine.   83
(Lebuffe et al., 2005) used a preoperative regimen of oral nicardipine as an alternative to 
phenoxybenzamine for phaeochromocytoma resection, they reported 27 out of 105 patients 
(26%) experienced a severe  SBP > 200 mmHg, 12% experienced persistent hypotension and 
30% experienced a tachycardia (heart rate >120bpm). Only 22% of procedures were 
performed laparoscopically. These results have not demonstrated an improvement in the 
perioperative haemodynamic stability compared to our current series. 
Few series have compared perioperative haemodynamic changes for LA for 
phaeochromocyotma with LA for other adrenal tumours. (Gotoh et al., 2002), compared 9 
patients undergoing LA for phaeochromocytoma with 28 patients undergoing LA for other 
adrenal tumours. In this study, hypertensive episodes were documented for the 
phaeochromocytoma group but not for the other adrenal tumours. In another recent study, 
(Weismann et al., 2006), compared 27 patients undergoing LA for phaeochromocytoma with 28 
patients undergoing LA for other tumours. For the phaeochromocytoma group, there were 
increased episodes of SBP>200mmHg with increased anti-hypertensive use, more episodes of 
tachycardia and hypotension. None of the patients received a phenoxybenzamine infusion and 
data on preoperative oral phenoxybenzamine usage was incomplete. Suitability for 
laparoscopic phaeochromocytoma resection was highly selective. Patient selection was not 
consecutive. Therefore, haemodynamic comparisons in these studies should be reviewed with 
caution. 
In the present study, all patients received an infusion of phenoxybenzamine the day before 
surgery and the only contraindication to the laparoscopic approach was adrenal tumour local 
invasion. Persistent hypertensive episodes were more frequent in the phaeochromocytoma 
group (similar to Weissmann et al) but there were no other perioperative haemodynamic 
differences between groups.  
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We agree with other authors (Kinney et al., 2000)(Kercher et al., 2002)(Cheah et al., 2002), 
that the marked improvement in morbidity and mortality in phaeochromocytoma resection since 
the 1950s is attributed to a number of factors: experienced endocrine, anaesthetic, surgical 
team, improved pre and perioperative pharmacological treatment for hypertension and 
arrhythmias, improved tumour localisation and improved surgical technique. 
Conclusion 
This study has demonstrated, in the presence of an experienced multidisciplinary team and 
complete preoperative alpha blockade, laparoscopic adrenalectomy for phaeochromocytoma 
can be accomplished with low perioperative haemodynamic complications. 
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6. The role of laparoscopic adrenalectomy for adrenal tumours of 6cm or greater  
     
6.1 Introduction 
Since it was introduced in 1992(Gagner et al., 1992), laparoscopic adrenalectomy (LA) has 
become the procedure of choice for most adrenal pathologies. It is uncertain if the laparoscopic 
resection of large (≥6cm) potentially malignant adrenal tumours is appropriate due to concern 
over incomplete resection and local recurrence (Henry et al., 2002)(Walz et al., 2005)(Schell et 
al., 1999)(Pisanu, Jafari, Pattou, Carnaille, & Proye, 2001)(Valeri et al., 2001). For this reason, 
selection of those suitable for laparoscopy is practised by many surgeons and this may bias 
outcomes. Therefore the favourable results of LA for large adrenal tumours in previous 
published series should be interpreted with caution.  
The aim of the present study was to compare the outcomes of LA for tumours ≥6cm with those 
<6cm from a consecutive series of patients where selection was practised infrequently. The 
only contraindications to the laparoscopic approach, in the present series, were radiological 
locally advanced adrenal tumours requiring en-bloc resection of adjacent organs or the 
requirement of an additional open procedure.   
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6.2 Methods 
Details of all patients referred with adrenal tumours between January 1999 and January 2009 
were recorded prospectively on a database. Preoperative, intraoperative and postoperative 
data were obtained from retrospective case note review. 
All patients were assessed preoperatively by the endocrine unit as previously described 
(Introduction 1.4.2).  
The adrenal tumours were imaged using computed tomography (CT) and/or magnetic 
resonance imaging (MRI). Maximum diameter of the adrenal tumour was then measured. 
A diagnosis of possible adrenal carcinoma was based on the patient history and radiology 
findings.  Morphology appearances which suggest malignancy may include: increased size 
(≥6cm), large necrotic areas, increased heterogeneity, irregular borders and local invasion. 
The only contraindications to LA were locally invasive adrenal mass on CT or MRI or the 
requirement of an additional open surgical procedure. If the adrenal local invasion involved only 
the kidney a LA and en-bloc nephrectomy was performed.  
Preoperative information included age, sex, diagnosis and co-morbidity. Intraoperative 
information included total anaesthetic time, requirement of blood products and operative 
complications. Postoperative information included complications, intensive care admissions, 
length of hospital stay, histopathology and tumour size. Any evidence of tumour recurrence or 
mortality on follow up was also recorded to July 2009. Therefore the operative outcomes of 
adrenal tumours ≥6cm versus those <6cm could be compared. 
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Statistical analysis 
Categorical variables were compared using Chi-square test. Continuous data are presented as 
median and interquartile ranges (IQR) and analysed with the Mann-Whitney test. A p value of 
<0.05 was assumed to be significant. Analyses were performed using SPSS (Version 17.0). 
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6.3 Results 
Characteristics of patients referred with adrenal tumours 
During the ten year period 180 patients were referred for adrenalectomy. Figure 6.1 illustrates 
the outcome of patients referred for adrenalectomy. 
Figure 6.1 Outcome of patients referred for adrenalectomy 
 
 
*  One patient had further debulking of recurrent adrenocortical carcinoma, 3 patients had 
asynchronous adrenalectomy because of further adrenal gland pathology [Cushing’s syndrome 
(n=2), phaeochromocytoma (n=1)]. 
Eight patients were deemed unsuitable for resection: unfit for resection (n=3), metastatic 
adrenocortical carcinoma (n=4) and one patient with a small (1 cm) non functioning adenoma. 
172 patients underwent 193 adrenalectomies (17 bilateral, 4 delayed contralateral 
adrenalectomies). Indication for bilateral adrenalectomy included: Cushing’s disease (n=11), 
phaeochromocytoma (n=4), and isolated adrenal metastasis (n=2). Indication for the 4 delayed 
180 patients 
referred for 
adrenalectomy  8 patients 
unsuitable for 
resection 
172 patients  underwent 
193 adrenalectomies 
     (17 bilateral) 
     (2 procedures for 
      4 patients*) 
176 laparoscopic 
adrenalectomies 
17 open 
adrenalectomies   89
contralateral adrenalectomies are given in Figure 5.1.  There were 176 laparoscopic 
adrenalectomies and 17 open procedures. Characteristics of patients undergoing LA are shown 
in Table 6.1. 
Table 6.1 Characteristics of patients undergoing laparoscopic adrenalectomy 
 
Characteristics 
 
 
 
Number of patients  156 
Number of adrenalectomies  176 
Sex ratio (M:F)  66:90 
Age*  57 (47-65) 
Tumour site 
Left 
Right 
Bilateral 
 
72 
70 
17 
Indication for referrala,b 
Conn’s adenoma 
Phaeochromocytoma 
Cushing’s syndrome 
Cushing’s disease 
Non functioning adrenal tumour 
Suspected adrenal carcinoma 
Suspected adrenal metastasis 
Mixed secreting adenoma 
Adrenal cyst 
 
38 
44 
25 
9 
8 
20 
12 
2 
1 
*Values are median (IQR) 
 
 
 
 
 
 
 
Operative data 
Operative data for laparoscopic procedures are shown in Table 6.2. 
Table 6.2 Intraoperative outcome 
  
 
Tumours 
≥6cm 
 
 
 Tumours 
  <6cm 
 
 
P value   90
(operations=62) 
 
  (operations=97) 
   
 
Total anaesthetic time for 
unilateral LA (mins)* 
 
 
Conversions 
 
 
Operative complications 
 
  Blood loss (>500mls) 
   
   
   
 
 
120 (90-145) 
 
 
 
6 
 
 
 
 
6 
 
 
 
 
 
 
 
 
 
 
 
100 (80-125) 
 
 
 
2 
 
 
 
 
2 
 
 
 
 
 
 
 
 
 
 
 
0.039 
 
 
 
0.077 
 
 
 
 
0.077 
* Values are median (IQR) 
 
69 out of 176 LA were performed for patients with a maximum tumour diameter measuring 6 
cm or more. The median total anaesthetic time for large adrenal tumours (≥6cm) was 
significantly longer compared to smaller adrenal tumours (<6cm) (120 minutes [IQR 90-145] 
versus 100 minutes [IQR80-125]; P=0.039). 
3 patients had LA with en-bloc nephrectomy: suspected local invasion (n=2) or renal carcinoma 
with bilateral adrenal metastases (n=1). Pathology showed: adrenocortical carcinoma (n=2) 
and clear cell renal carcinoma with bilateral adrenal metastases. 
Conversion to an open procedure was necessary for 8 patients. 6 conversions were for patients 
with tumours ≥ 6cm. 3 were converted due to concern over adjacent structure invasion. One 
patient undergoing combined adrenalectomy and nephrectomy for presumed adrenocortical 
carcinoma was converted due to splenic bleeding (blood loss, 600mls), open splenectomy was 
required. One patient undergoing bilateral adrenalectomy for Cushing’s disease was converted 
on the right side due to adhesions after a previous open cholecystectomy. The other patient 
with a possible phaeochromocytoma on preoperative assessment (catecholamines upper limit   91
of normal) was converted because the tumour was found to originate from the kidney and 
therefore a radical nephrectomy was performed. There were 2 conversions for tumours <6cm: 
one to achieve haemostatic control after an adrenal vein tear and the other due to dense 
adhesions to liver and colon after previous ipsilateral nephrectomy. 
For patients with adrenal tumours ≥6cm, 6 had a blood loss >500mls. 3 out of the 6 were for 
converted patients (n=2) or simultaneous laparoscopic nephrectomy (n=1). The remaining 3 
were for patients with phaeochromocytoma. For patients with adrenal tumours <6cm, 2 had 
blood loss >500mls. One was for a patient with bilateral phaeochromocytoma and multiple 
friable vessels and the other was for bleeding from a left renal vein. Haemostasis was achieved 
laparoscopically in both patients. No patient required intraoperative blood transfusion. 
All patients undergoing LA had clear resection margins. 
 
 
 
 
 
 
 
 
 
 
 
 
Postoperative data    92
The median post-operative stay (which included patients converted to open) for patients 
undergoing LA for tumours ≥ 6cm was significantly different from tumours<6cm (3 days [IQR 2-
5] versus 2 days [IQR2-3]; P<0.005) (Table 6.3). 
Table 6.3 Postoperative outcome 
   
 
Tumours 
≥6cm 
(operations=62) 
 
 
Tumours 
<6cm 
(operations=97) 
 
 
P value 
 
 
 Post operative complications 
 
    Arrhythmia 
 
    Pneumonia 
 
    Subphrenic collection 
     
    Port site bleed 
 
    Wound infection (In hospital) 
 
    Acute renal failure 
   
    Pulmonary embolism 
 
    Urinary tract infection 
 
Total complications 
 
    
Post operative stay (days)* 
(includes those converted to open) 
     
 
   
 
 
 
 
1 
 
5 
 
1 
 
0 
 
1 
 
1 
 
0 
 
1 
 
10 
 
 
3 (2-5) 
 
 
 
 
0 
 
2 
 
1 
 
1 
 
3 
 
1  
 
1 
 
0 
 
9 
 
 
2 (2-3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.295 
 
 
< 0.005 
* Values are median (IQR) 
 
  
Out of the 159 laparoscopic procedures performed, there was no significant difference for 
complications between the 2 groups (10 (≥6cm) versus 9 (<6cm); P=0.295). Laparoscopic 
complications between the two groups are summarised in Table 6.3. There were no post-
operative mortalities after laparoscopic adrenalectomy. 
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Follow up 
For patients undergoing LA, the median follow up was 41 months [IQR 22-76]. In this time there 
have been no clinical or radiological evidence of local recurrence for patients undergoing LA. 3 
patients have developed metastatic disease. One has diffuse intrabdominal disease 5 years 
after the complete laparoscopic resection of a 5cm phaeochromocytoma. The other 2 patients 
have developed distant metastatic disease after laparoscopic resection of large (>6cm) 
adrenocortical carcinomas. There have been 6 cancer related deaths after LA: 2 after resection 
of adrenal metastasis (metastatic melanoma (n=1), metastatic neuroblastoma (n=1), one with 
B-cell lymphoma, one with an unrelated metastatic adenocarcinoma (previously resected 
phaeochromocytoma), one with pulmonary metastasis after resection of adrenocortical 
carcinoma and the other from metastatic medullary thyroid carcinoma (previous bilateral 
phaeochromocytomas in a patient with MEN type 2b).  
 
 
 
 
 
 
 
 
 
 
6.4 Discussion 
Out of the 176 laparoscopic adrenalectomies performed, 69 (39%) were for adrenal masses 
≥6cm. There were increased conversions in this group, mainly for concern over local tumour   94
invasion. Post operative stay for patients with adrenal tumours ≥6cm was a day longer 
compared to those <6cm (3 days versus 2 days). After a median follow up of 41 months, there 
has been no clinical or radiological evidence of local recurrence in any patient that has had an 
attempted laparoscopic approach. 
Adrenal masses ≥6cm are generally regarded as having a high risk of malignancy. Therefore 
many surgeons do not attempt LA for large adrenal tumours due to concern over incomplete 
resection and local recurrence. However, an increasing number of series have demonstrated 
the safety of this approach together with low rates of local recurrence (Table1.6). But, the 
percentage of patients with tumours ≥6cm was significantly lower than our series suggesting 
selection bias. For example only 7% (33 out of 429) of LA were for large adrenal tumours in a 
series by (Walz et al., 2005)  . This was also illustrated by (MacGillivray et al., 2002), 20% (12 
out of 60) of LA were performed for large adrenal tumours. Henry et al demonstrated excellent 
results for laparoscopic resection of possible malignant tumours in 19 patients (Henry et al., 
2002). However these patients were selected from a series of 233 LA. Similar outcomes were 
achieved by Palazzo et al but again only 5% (19 out of 391) of LA were for tumours ≥6cm 
(Palazzo et al., 2006). Ramacciato et al, reported the experience of LA for adrenal tumours > 
7cm (Ramacciato et al., 2008). 18 out of 107 patients had LA for adrenal mass >7cm. 
Complications were low and there were no cases of incomplete resection or local recurrence. 
There was no mention of selection criteria for laparoscopy or the number of patients requiring 
an open procedure. Therefore, due to the selection bias that may exist in these series the 
encouraging results should be reviewed with some caution. 
Unlike these series, the present study included all patients referred with adrenal tumours and a 
significant higher percentage (43%) had large tumours with the majority (80%) undergoing 
attempted laparoscopic resection. Selection for laparoscopy has remained constant in the 10 
year study period. 3 patients underwent LA with en-bloc nephrectomy with low morbidity and   95
good oncological outcome. In patients with local invasion into structures other than kidney we 
feel, like other series, an open approach for these tumours provides the best chance of 
complete resection and allows vascular control of major vessels when required.  
 
Mean conversion rate for selected large series has been reported as 3.6%. Conversion was 
slightly higher in the present series (4.5%). The reasons for lower number of conversions in 
other series may include: selection for those suitable for laparoscopy changed dramatically 
over time or laparoscopic resection of large adrenal tumours was not practised. 
Although not statistically significant, there were more conversions for adrenal tumours ≥6cm 
compared to those <6cm (10% versus 2%). The main reason for the difference was concern 
over local invasion for patients with larger adrenal tumours. We feel the open technique allows 
the best chance to achieve complete resection in these cases. 
 
 
Radiological assessment of tumour size can be used to predict the likelihood of malignancy. In 
a risk assessment study of 457 adrenal cortical carcinomas, (Sturgeon et al., 2006), reported a 
four fold increase in malignancy for adrenal tumours ≥6cm. In the current series, out of 69 LA 
performed for tumours ≥ 6cm, 10 had a histological diagnosis of adrenal cortical carcinoma 
based on the Weiss criteria. Adrenal resection for these patients was complete without 
evidence of local recurrence after a median follow up of 41 months. This compares very 
favourably with other studies who document the mean disease free interval for adrenal cortical 
carcinoma, even after a curative operation, is approximately 12-22 months. We feel like other 
authors, adopting a policy of LA only for tumours <6cm or highly selecting those with tumours 
>6cm would prevent a large number of patients receiving the benefits of the laparoscopic 
approach. Even in the presence of malignancy, we have shown laparoscopic resection can   96
achieve very favourable oncological outcomes after long-term follow-up. The laparoscopic 
approach gives an excellent view of large tumours and radical resection with a low blood loss 
can be performed without the need for large abdominal or thoracoabdominal incisions in these 
patients. 
 
 
LA for non-invasive very large masses (≥ 10cm) has been described (Ramacciato et al., 
2008)(Shen, Kebebew, Clark, & Duh, 2004)(Gagner et al., 1997). There were 9 patients with 
adrenal tumours ≥ 10cm in this series. Authors have commented on the difficulty in 
mobilisation, tedious dissection and limited working space (Assalia & Gagner, 2004). Despite 
this, in the current series, we felt laparoscopic mobilisation of these very large adrenal tumours 
would allow the benefits of a smaller targeted incision to remove the specimen rather than the 
morbidity associated with a large subcostal or thoracoabdominal incision from the outset. The 
favourable outcome of this approach has been demonstrated in terms of low postoperative 
morbidity, hospital stay (median of 4 days) and favourable oncological outcomes. 
An alternative laparoscopic assisted approach has been described for these very large 
tumours. (Shen et al., 2004) have described the utilisation of a hand port for adrenal masses 
that cannot be completed laparoscopically. The authors used a hand assist device (Pneumo-
Sleeve, Dexterity Surgical; or Lap Disk, Ethicon) inserted as a 6-8cm subcostal incision. The 
hand assist device was used successfully in 4 out of the 261 LA: large (>15cm) masses (n=2) 
and concern over local invasion (n=2). The device was reported to facilitate dissection and help 
detect evidence of local invasion. However, no difference in terms of complications or hospital 
stay was detected between hand assist and the open converted procedures. The authors 
acknowledge larger numbers of patients are required before differences would become 
apparent. Although the hand assist device was not used in the present series, we believe this   97
technique is an alternative in situations with very large (>10cm) adrenal masses or concern 
over local invasion. 
 
In the absence of local invasion, this study has shown the oncological outcome and 
postoperative morbidity of laparoscopic adrenalectomy for patients with tumours ≥6cm was 
comparable to those with tumours <6cm. Post-operative stay was a day longer (3 rather than 2 
days). Concern over incomplete resection and local recurrence for these large adrenal tumours 
has not been realised. This series has helped confirm a policy of initial laparoscopic resection 
for all non-invasive adrenal tumours can be applied safely. This would prevent patients 
undergoing unnecessary open procedures and allow the benefits of laparoscopy. 
  
 
 
 
 
 
 
 
 
 
 
7 The role of open adrenalectomy in the laparoscopic era 
7.1 Introduction 
Many case series have reported the success of laparoscopic adrenalectomy (LA) for the 
majority of adrenal pathologies. However, the true incidence and outcomes of patients   98
undergoing open adrenalectomy (OA) within these series were unclear. Reasons include: 
failure to report details of those undergoing OA or the role of laparoscopy has expanded over 
time to include large potentially malignant tumours.  
The current study aimed to look at the outcome of patients undergoing OA in a consecutive 
series of patients where selection for LA was constant during a 10 year period. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.2 Methods 
From January 1999 to January 2009, details of all patients referred for adrenalectomy were 
recorded prospectively on a database. Analysis was performed retrospectively.   99
Prior to starting laparoscopic adrenalectomy in January 1999, laparoscopic experience 
included: cholecystectomy, nephrectomy and colonic resection. A sound knowledge of the 
retroperitoneal anatomy had also been achieved by regular resection of abdominal sarcomas. 
All patients were assessed preoperatively by the endocrine unit. The adrenal tumours were 
imaged CT and/or MRI. 
LA was performed using the lateral transabdominal approach as described and illustrated in the 
Introduction (1.8.3). Techniques for open adrenalectomy are described in the Introduction 
(1.8.7). Indicators for open adrenalectomy were locally invasive adrenal mass or the 
requirement of an additional open surgical procedure. 
Data on in-hospital perioperative outcomes, follow-up (local recurrence, distant metastatic 
disease and post operative endocrine function) were collected. 
 
 
 
 
 
 
 
 
 
 
 
Statistical analysis   100
Categorical variables were compared using Chi-square test. Continuous data are presented as 
median and interquartile ranges (IQR) and analysed with the Mann-Whitney test. A p value of 
<0.05 was assumed to be significant. Analyses were performed using SPSS (Version 17.0). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.3 Results   101
Preoperative 
During the ten year period 180 patients were referred for adrenalectomy. Figure 6.1 illustrates 
the outcome of patients referred for adrenalectomy. 172 patients underwent 193 
adrenalectomies. There were 176 laparoscopic adrenalectomies and 17 open procedures.  The 
indications for the 17 open procedures were: local invasion (n=8), requirement of an additional 
open procedure (n=3), recurrent adrenal tumour (n=2), previous radical retroperitoneal 
lymphadenectomy (testicular teratoma) (n=1), sarcoma arising from adrenal (n=1), preoperative 
diagnosis of sarcoma (final diagnosis phaeochromocytoma) (n=1) and the emergency resection 
of a large (12cm) phaeochromocytoma (unable to adequately control blood pressure in the 
intensive care unit). Characteristics of patients undergoing OA are shown in Table 7.1. 
Table 7.1 Characteristics of patients undergoing open adrenalectomy 
  Open adrenalectomy 
Number of patients  16 
Number of adrenalectomies  17 
Sex ratio (M:F)  10:6 
Age*  60 (43-72) 
Tumour site 
Left 
Right 
 
5 
12 
Indication for referral 
Phaeochromocytoma 
 
 
Non functioning adrenal tumour 
Suspected adrenal carcinoma 
Recurrent adrenal carcinoma 
Suspected adrenal metastasis 
Adrenal sarcoma 
 
3 
 
 
1 
9 
1 
1 
2 
*Values are median (IQR) 
 
 
 
 
 
Operative data   102
Operative data for adrenalectomies are shown in Table 7.2. 
Table 7.2 Operative outcomes comparing open and laparoscopic adrenalectomy 
  
 
 Open  
 adrenalectomy 
  (operations=17) 
   
 
 
Laparoscopic 
adrenalectomy 
(operations=159) 
 
 
P value 
 
Total anaesthetic time for 
unilateral adrenalectomy 
(mins)* 
 
Structure resection due to 
local invasion 
  
   Inferior vena cava  
   Kidney 
   Diaphragm 
   Colon 
   Liver 
   Spleen 
 
 
  Blood loss (>500mls) 
   
   
   
 
 
150 (120-195) 
 
 
 
 
 
 
1 (tumour thrombus) 
4 
1 
1 
1 
1 
 
 
13 
 
 
 
110 (85-135) 
 
 
 
 
 
 
- 
5 
- 
- 
- 
1 
 
 
8 
 
 
<0.005 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.005 
* Values are median (IQR) 
 
The total anaesthetic time for OA was significantly longer than LA. The open procedures were 
often complex procedures associated with significant greater blood loss and increased 
requirement for en-bloc resection of adjacent structures due to local invasion (Table 7.2). 2 
patients required thoraco-abdominal procedures to allow adequate access. One patient with an 
adrenocortical carcinoma had inferior vena cava exploration to excise tumour thrombus. 
2 patients had incomplete resection following open procedures: adrenal cortical carcinoma 
(n=1) and sarcoma originating from the adrenal (n=1).    
 
 
 
Postoperative data   103
Table 7.3 summarises the postoperative outcomes. The median post-operative stay for patients 
undergoing OA was significantly longer compared to those undergoing LA. 
Table 7.3 Post-operative outcomes comparing open and laparoscopic adrenalectomy 
   
 
Open 
adrenalectomy 
(operations=17) 
 
 
Laparoscopic 
adrenalectomy 
(operations=159) 
 
 
P value 
 
 
 Post operative complications 
 
    Arrhythmia 
 
    Pneumonia 
 
    Subphrenic collection 
     
    Port site bleed 
 
    Wound infection (In hospital) 
 
    Acute renal failure 
   
    Pulmonary embolism 
    
    Urinary tract infection 
 
    Small bowel fistula 
 
Total complications 
 
 
Mortality 
 
     
Post operative stay (days)* 
     
 
   
 
 
 
 
- 
 
3 
 
2 
 
- 
 
2 
 
2 
 
- 
 
1 
 
1 
 
11 
 
 
1 
 
 
9 (6-19) 
 
 
 
 
1 
 
7 
 
2 
 
1 
 
4 
 
2 
 
1 
 
1 
 
- 
 
19 
 
 
- 
 
 
3 (2-4) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<0.005 
 
 
 
 
 
<0.005 
* Values are median (IQR) 
 
One patient undergoing open adrenalectomy died in the early postoperative period. The 
adrenal pathology was a non-functioning adenoma and was performed open because a 
synchronous left hemicolectomy was required for complicated diverticular disease. In the early 
postoperative period, the patient developed a perforated peptic ulcer (subsequently oversewn) 
and then died due to multi-organ failure. 
Follow-up   104
For patients in the OA group, after a median follow-up of 65 months (IQR 20-87), there have 
been 6 local recurrences: adrenocortical carcinoma (n=4) and spindle cell sarcoma originating 
from adrenal gland (n=2). One patient with recurrent adrenocortical carcinoma underwent a 
repeat resection with en-bloc nephrectomy. This patient has subsequently developed liver 
metastasis. 2 patients with adrenocortical carcinoma have died. Both patients developed 
distant metastases and local recurrence.  
3 patients undergoing open adrenalectomy for phaeochromocytoma have had no evidence of 
recurrence, metastatic disease or catecholamine excess.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.4 Discussion   105
Out of the 193 consecutive adrenalectomies, 17 (9%) were performed as an open procedure. 
The main reason for OA was evidence of local invasion on pre-operative imaging (8 out of 17). 
This was confirmed at laparotomy and was associated with adjacent structure resection. 6 
patients had evidence of local recurrence on follow-up. 
 
Since LA was introduced in 1992, many series have reported the success of LA in consecutive 
series of patients. In these series it has been difficult to interpret the true incidence or outcomes 
of patients undergoing OA as selection for laparoscopy changed over the time period or the 
open data was not reported. (Soon et al., 2008), in a series of 177 adrenalectomies performed 
26 OA (15%). But did not give any details about which patients were suitable for laparoscopy. 
In another series (Palazzo et al., 2006) documented the results of a large series of 
adrenalectomies. Over a 10 year period, out of 462 adrenalectomies, 71 were open (15%). OA 
was performed when malignancy was suspected on preoperative imaging. Out of the 71 OA, 
no outcome data was available. The outcome of patients undergoing OA within a laparoscopic 
series remains largely unknown. 
In the present series the selection of patients for open adrenalectomy remained unchanged in 
the 10 year period. Using these criteria, the number of OA was lower (9%) compared to other 
series. The main reason for open procedure (8 out of 17) was concern over local invasion. 
Other reasons included previous extensive retroperitoneal dissection, recurrent tumour or 
suspected retroperitoneal sarcoma. The patient outcomes were often associated with high 
blood loss and prolonged hospital stay. 
    
Malignancy is highly suspected in the presence of local invasion by CT or MRI. In this situation, 
we agree with other authors that the requirement of extensive en-bloc resection of invaded 
organs is best performed by the open approach (Henry et al., 2002). The present series shows   106
the extensive dissection required including adjacent structure involvement: kidney, liver, 
spleen, colon and inferior vena cava. We have shown in Chapter 5 in the absence of local 
invasion LA can be performed safely with good oncological outcome and postoperative 
recovery. 
Adrenocortical carcinoma has a poor prognosis with 5 year survival rates varying from 16-38% 
(Vassilopoulou-Sellin & Schultz, 2001). Surgery remains the only potential for cure. For patients 
who have had potentially curative surgery local recurrence rates of 20-30% have been 
reported. This compares with our series, out of 15 patients with adrenocortical carcinoma, 4 
have had a local recurrence. These all occurred in the open group. One patient with local 
recurrence has had repeat resection. This is an accepted option for patients with recurrent 
disease and has been associated with improved survival (Bellantone et al., 1997). 
  
In summary, we have demonstrated with an appropriate experienced team consisting of 
surgeons, anaesthetists, radiologists and endocrinologists, laparoscopic resection can be 
attempted safely with low morbidity in the majority (92%) of patients deemed suitable for 
adrenalectomy. Open adrenalectomy when indicated (mainly for local invasion) was a 
demanding procedure associated with resection of adjacent structures and high local 
recurrence rates. 
 
  
 
 
 
 
 
8 Laparoscopic adrenalectomy for isolated adrenal metastasis   107
8.1 Introduction 
Resection of isolated adrenal metastasis (AM) has been reported to prolong survival when 
compared to patients who have had non-operative management (Kim, Brennan, Russo, Burt, & 
Coit, 1998a) (Luketich & Burt, 1996)(Sarela, Murphy, Coit, & Conlon, 2003). 
Laparoscopic adrenalectomy (LA) has become the procedure of choice for the majority of 
adrenal pathologies.  
However, only a few series have focussed on the role of LA for isolated AM. (Strong et al., 
2007) in one of the largest series of 94 adrenalectomies for isolated AM compared the results 
of LA to open adrenalectomy. This showed improved recovery with similar oncological results 
for LA patients. However, selection for laparoscopy was practised in that the mean size of 
tumour was 3.8cm in the LA group compared to 6.4cm for the open group. Therefore, the 
favourable results for laparoscopy in this select group of patients may not hold true for patients 
with larger adrenal masses. 
The aim of the present study was to evaluate the results of LA for isolated AM in a consecutive 
series of patients where the only contraindication to laparoscopy was local invasion on 
preoperative imaging. 
 
 
 
 
 
 
 
 
8.2 Methods   108
From January 1999 to January 2009, details of all patients referred for adrenalectomy were 
recorded prospectively on a database. 
A diagnosis of suspected adrenal metastasis was based on clinical history and CT or MRI 
findings. Indications for adrenalectomy were curative intent for solitary adrenal metastasis and 
diagnostic intent for suspected adrenal metastasis. 
A metachronous metastasis was defined as adrenal metastasis appearing ≥6 months after 
initial diagnosis. 
Data on in-hospital outcomes, follow-up and mortality were collected by case note review. 
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Out of the 176 LA, 12 patients were suspected as having isolated adrenal metastasis. Median 
age was 61 (interquartile range (IQR) 54-73). There were 9 males and 3 females. No patient 
had a preoperative adrenal biopsy. 
Patient characteristics are summarised in Table 8.1. 11 patients presented with metachronous 
AM and 1 patient presented with synchronous AM. 9 of the 12 patients presented with AM of 
suspected renal cell carcinoma origin. Of the 8 patients with suspected metachronous renal 
origin metastasis, 4 were ipsilateral AM. 
Table 8.1 Patient characteristics with isolated adrenal metastasis 
Patient Primary 
tumour 
S/M Side  Size 
(mm) 
Conversion  TAT 
(mins) 
Hospital 
stay 
(days) 
Pathology Follow
-up 
Status 
1 Kidney  S  Bilat  Right  72 
Left 70 
-  305  14  AM 23  ANED 
2 Melanoma  M  Left  90  -  120  3  AM 13  DOFD 
3 Kidney  M  Left  70  -  80  3  AM 16  AWD 
4 Olfactory 
neuroblastoma 
M Bilat  Right  80 
Left 70 
-  195  2  AM 45  DOFD 
5 Kidney  M  Right  40  yes  140  17  AM 7  AWD 
6 Kidney  M  Right  27  -  75  2  AM 21  AWD 
7 Kidney  M  Left  32  *  120  60  AM 26  ANED 
8 Kidney  M  Left  40  -  120  3  AM 16  ANED 
9 Kidney  M  Left  20  -  65  3  AM 12  ANED 
10 Kidney  M  Left  40  -  105  3  AM 9  ANED 
11 Kidney  M  Right  20  -  200  3  Adenoma 11  AWD 
12 Unknown M  Left  17  -  110  2  Adrenal 
gland 
necrosis 
81  ANED 
S: synchronous; M: metachronous 
* Patient underwent laparoscopic distal pancreatectomy and splenectomy due to concern over local invasion 
 TAT: total anaesthetic time 
AM: adrenal metastasis 
AWD: alive with disease, ANED: alive with no evidence of disease, DOFD: dead of disease 
 
All patients underwent initial LA. The median total anaesthetic time for unilateral LA was 115 
(IQR80-125). There was one conversion for an ipsilateral right metachronous renal origin AM 
due to dense adhesions involving colon, liver and inferior vena cava. Another patient with an 
ispilateral left AM underwent an en-bloc laparoscopic distal pancreatectomy and splenectomy 
due to concern over local invasion.    
There were 3 post-operative complications: left upper quadrant collection in the patient with 
local invasion to spleen and pancreas, pneumonia in the converted patient and a urinary tract   110
infection in another. Hospital stay was 60, 17 and 14 days respectively in these patients. For 
other patients the hospital stay ranged from 2-3 days. 
 On histological examination there were no cases of incomplete adrenal resection. 2 patients 
did not have evidence of adrenal metastatic disease. 
After a median follow-up of 16 months (IQR 11-25), 2 patients have died due to disseminated 
disease (metastatic melanoma (n=1) and metastatic olfactory neuroblastoma (n=1). All 9 
patients with renal origin AM were alive after follow-up. Of the 9, 4 are alive with disease (lung 
metastasis (n=2), lymph node metastasis (n=2)). 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.4 Discussion   111
In a highly select group of patients, surgery for isolated AM has been shown to improve 
survival. It is not clear if laparoscopic adrenalectomy results in less morbidity or worse 
oncological outcome compared to open adrenalectomy for these patients. In the current study, 
we report our experience of LA in patients with suspected isolated AM. Over the 10 year 
period, 12 out of 176 LA were for suspected isolated AM. LA was associated with low morbidity 
and short hospital stay [median 3 days (IQR2-11)]. All adrenal masses were completely 
resected and there has been no evidence of local recurrence on follow-up. All patients with 
renal origin AM were alive in the follow-up period.  
Other series have reported the experience of LA for isolated AM. (Sebag et al., 2006), reported 
the experience of 16 LA for AM. The mean hospital stay was 5 days with minor complications 
occurring in 3 patients. The authors felt LA gave an acceptable oncological outcome with 
improved recovery when compared to open surgery. Indicators for laparoscopy or open surgery 
were not given. (Bonnet et al., 2008) reported the outcome of 8 LA for metachronous 
metastasis from renal cell carcinoma. There were no post-operative complications and the 
median hospital stay was 3 days. The series reported excellent disease-free survival of 87% 
after 39 month follow-up. LA was not performed for large masses (>10cm). In a large series, 
(Strong et al., 2007)  compared 31 LA versus 63 open adrenalectomies (OA) for isolated AM. 
The authors found LA gave equivalent oncological results to OA but laparoscopy allowed 
improved recovery with lower morbidity. However, the results should be interpreted with caution 
as the patients in the open group had larger adrenal masses (6.4cm for OA versus 3.8cm for 
LA). 
In the present study the only contraindication to laparoscopy was a locally invasive adrenal 
mass on preoperative imaging. Using these criteria for laparoscopy, we report similar 
encouraging results in terms of complications and hospital stay after LA for isolated AM 
compared to other series. LA for renal origin AM appeared to have the best outcome, in   112
agreement with Bonnet and colleagues. LA for other AM, in our series, was associated with a 
dismal prognosis. It is difficult to draw any conclusions from this as there were only 2 patients 
with AM from primaries other than renal cell carcinoma.  
We know once a patient has a diagnosis of an extraadrenal malignancy, the chance that an 
incidentally detected adrenal mass is malignant increases substantially (Young, 2007). 
Therefore, unless a lesion on CT or MRI conforms to strict criteria for benignity, AM should be 
strongly considered. We used similar criteria to Bonnet and colleagues, LA was considered in 
any patient with known extraadrenal malignancy and an isolated adrenal lesion >2cm or an 
adrenal mass increasing in size on serial imaging. In the current series, using these criteria, 10 
out of 12 patients confirmed the diagnosis of AM. One patient with suspected bilateral AM had 
no history of extraadrenal malignancy. AM was suspected as the patient had bilateral necrotic 
adrenal masses (CT scan performed for unrelated pathology). A diagnostic unilateral 
adrenalectomy was performed and pathology showed adrenal gland necrosis only. 
In the current series, there were 3 patients with ipsilateral metachronous renal origin AM. All 
procedures were technically difficult due to adhesions. 2 were performed without complication. 
The other was converted due to dense adhesions involving liver, IVC and colon. We agree with 
Bonnet et al that LA for ipsilateral metachronous renal origin AM, although feasible, were all 
technically more demanding. 
In conclusion, we have shown in a highly selected population LA can be performed with low 
morbidity and good oncological outcomes for the majority of patients with isolated renal origin 
AM. Patients with isolated AM from other sites appeared to have a much worse prognosis on 
follow-up. However, larger patient numbers and longer follow-up are required.    
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Laparoscopic adrenalectomy has become the procedure of choice for most adrenal 
pathologies. Many case series have demonstrated the benefits in terms of blood loss, 
morbidity, analgesic requirements and hospital stay compared to the traditional open 
technique. However, a number uncertainties related to the laparoscopic procedure remain.  
The thesis aimed to look at some of these uncertainties. As stated in Chapter 2 the aims were: 
1. To document the surgical importance of variable vein anatomy and multiple periadrenal 
vessels during laparoscopic adrenalectomy. 
2. To review the importance of the adrenal gland blood supply when performing a laparoscopic 
subtotal adrenalectomy.  
3. To look at the perioperative haemodynamic changes in patients undergoing laparoscopic 
adrenalectomy for phaeochromocytomas and other adrenal tumours. 
4. To assess the role of laparoscopic adrenalectomy for adrenal tumours of 6cm or greater. 
5. To assess the outcomes of open adrenalectomy in a consecutive series of patients referred 
with adrenal tumours. 
6. To assess the role of laparoscopic adrenalectomy for patients with isolated adrenal 
metastasis. 
 
Chapters 3 and 4 examined different aspects of adrenal gland vasculature. 
Chapter 3 examined the surgical importance of variable vein anatomy and multiple periadrenal 
vessels during LA. The study showed, with the magnified view (2.5-3 times normal) at 
laparoscopy, the main adrenal venous drainage (and any variants) could be clearly defined for 
all patients. The majority of patients (97%) had constant venous drainage. No bleeding 
complications or conversions resulted from failure to recognise the main adrenal vein and its 
variants. Other multiple, small periadrenal vessels were noted at time of laparoscopy for all 
patients. It was not possible to distinguish between small veins and arteries. These periadrenal   114
vessels were all small enough to be controlled with electrocautery or ultrasonic dissection. 
Adrenal vein variants and an increased number of periadrenal vessels appeared to occur in 
patients with phaeochromocytomas or large adrenocortical carcinomas. Increased attention to 
the adrenal gland vasculature may be required during LA for these patients. 
 
After showing the constant nature of the main adrenal veins for patients undergoing LA, the 
next aim was to examine the nature of the periadrenal vessels. This would be important when 
performing laparoscopic subtotal adrenalectomy as a satisfactory blood supply of the adrenal 
remnant is vital to preserve steroid function.  
Chapter 4 examined the importance of the adrenal gland blood supply when performing a 
laparoscopic subtotal adrenalectomy. This study has shown from cadaver dissection multiple 
small arteries and veins (in addition to the main adrenal vein) completely surround the adrenal 
gland. Using gross dissection and histological methods we demonstrated it was possible to 
follow the venous drainage from the adrenal gland to the peripheral veins. This has helped 
establish that these peripheral veins drain the adrenal gland. Therefore, during laparoscopic 
subtotal adrenalectomy, a non functioning adrenal remnant would be unlikely due to an 
inadequate arterial supply or due to division of the main adrenal vein. However, once the main 
adrenal vein is divided, excessive mobilisation of the adrenal remnant should be avoided to 
prevent destruction of the smaller peripheral veins necessary for venous drainage. 
  
 
Perioperative haemodynamic changes are well recognised sequelae of adrenalectomy for 
phaeochromccytomas. In the current series, we used a phenoxybenzamine regimen and felt 
complete alpha blockade was achieved in all cases. As a result, we felt using this regimen and 
a specialist endocrine, anaesthetic and surgical team the perioperative haemodynamic stability   115
of LA for phaeochromocytoma has improved to such a degree that they may now be 
comparable to LA for other non-catecholamine secreting adrenal tumours. 
Chapter 5 compared the perioperative haemodynamic changes in consecutive patients 
undergoing LA for phaeochromocytomas and other adrenal tumours. This study showed 
laparoscopic adrenalectomy for phaeochromocytoma was associated with increased episodes 
of severe intraoperative hypertension (systolic blood pressure=200-220mmHg) when compared 
to the laparoscopic resection of other adrenal tumours. These episodes were all controlled with 
anti-hypertensive medication. There were no other significant differences in terms of 
hypotensive episodes, cardiac arrhythmias or intravenous fluid requirements. This has 
demonstrated, in the presence of an experienced multidisciplinary team and complete 
preoperative alpha blockade, laparoscopic adrenalectomy for phaeochromocytoma can be 
accomplished with low perioperative haemodynamic complications. 
 
It is uncertain if the laparoscopic resection of large (≥6cm) potentially malignant adrenal 
tumours is appropriate due to concerns over incomplete resection and local recurrence. 
Chapter 6 compared the outcomes of LA for tumours ≥6cm with those <6cm. In the absence of 
local invasion, this study has shown the oncological outcome and post-operative morbidity of 
laparoscopic adrenalectomy for patients with tumours ≥6cm was comparable to those with 
tumours <6cm. Post-operative stay was a day longer (3 rather than 2 days). Concern over 
incomplete resection and local recurrence for these large adrenal tumours has not been 
realised. This has helped confirm a policy of initial laparoscopic resection for all non-invasive 
adrenal tumours can be applied safely. This would prevent patients undergoing unnecessary 
open procedures and allow the benefits of laparoscopy. 
Chapter 7 examined the outcomes of open adrenalectomy in a consecutive series of patients 
referred with adrenal tumours. We showed, in the laparoscopic adrenalectomy era, OA was   116
required infrequently. In the absence of the requirement for an additional open procedure, OA 
was a demanding procedure associated with resection of adjacent structures and high local 
recurrence rates. 
Chapter 8 examined the outcomes of laparoscopic adrenalectomy for patients with isolated 
adrenal metastasis. In the current series, the recovery and oncological outcomes for isolated 
adrenal metastasis from a renal origin compared very favourably to other series where a more 
selective policy for laparoscopy was adopted. 
 
There were a number of limitations in this study. The main observations from chapters 3-8 were 
based on a retrospective review of a case series (Level 4 evidence). Limitations from this type 
of study include: selection bias, incomplete or inaccurate data. However, from the present 
series, patients referred for adrenalectomy were reviewed by a single surgeon (PJOD) and 
entered on to a prospective database. Adrenalectomy was then performed by the same 
surgeon. This would enable totality of practice to be documented and reduce the risk of 
incomplete data. 
Ideally, from the present study, randomized controlled trials should be performed to confirm the 
observations. However, there are a number of reasons it seems unlikely these would be 
performed. Due to the rarity of adrenal tumours, it would not be possible to recruit a large 
enough number of patients to establish the studied outcomes. Another reason includes an 
existing body of evidence from case series giving overall consistent results. For example, 
chapter 6 documented the favourable postoperative and oncological outcomes of 
adrenalectomy for large noninvasive tumours (≥6cm). It was difficult to compare to other LA 
series for large tumours due to a number of limitations, including selection criteria and a low 
number of patients with large adrenal tumours. Despite this, the results of our series were 
consistent with the other retrospective case series. Therefore, despite the lack of strong   117
scientific evidence, it seems randomised prospective studies will not be performed and LA for 
large adrenal tumours has become an accepted procedure within experienced units. 
Chapter 5 was a retrospective study comparing the perioperative haemodynamic changes in 
consecutive patients undergoing LA for phaeochromocytomas and other adrenal tumours. 
Specific limitations to this chapter include the accuracy or completeness of pulse and blood 
pressure measurements manually recorded on to the anaesthetic charts. We used definitions 
of tachycardia, hypertension, hypotension and length of an event to try and reduce the chance 
of missing any major haemodynamic complications.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Further Work   118
It would be useful to know the rate of incisional hernia formation after long term follow-up 
following laparoscopic adrenalectomy. There are plans to examine this from the current cohort 
of patients. 
Also it would be important to further examine the role of the hand port for the laparoscopic 
resection of large adrenal masses >10cm. 
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